Modern medical care often involves the use of medication management systems that include medication delivery and monitoring devices such as medication delivery pumps or patient parameter monitors or both, Medication management systems for configuring, controlling and monitoring medication delivery devices have been disclosed. For example, commonly owned U.S. Pat. No. 7,895,053 titled “MEDICATION MANAGEMENT SYSTEM” that issued on Feb. 22, 2011 and U.S. patent application Ser. No. 10/783,573 titled “MEDICATION MANAGEMENT SYSTEM” that published as US20050278194A1 on Dec. 15, 2005 disclose a medication management system wherein user customizable drug library or medical device configuration information is prepared using a drug library editor (DLE) program and module of a medication management unit (MMU). Hospira MedNet™ Meds™ software available from Hospira, Inc. of Lake Forest, Ill., U.S.A. includes such a DLE program. The MMU, which is equipped with Hospira MedNet™ Server software, downloads the customizable drug library to the medication delivery pump and receives status or activity information from the pump. Commonly owned U.S. Pat. No. 8,065,161 titled “SYSTEM FOR MAINTAINING DRUG INFORMATION AND COMMUNICATING WITH MEDICATION DELIVERY DEVICES” that issued on Nov. 22, 2011 discloses how the drug library or medical device configuration information is created, edited, stored and communicated to a medication delivery device in the context of a medication management system to deliver substances, such as fluids or fluid medication or both to patients.
According to the above-mentioned commonly owned published patent applications, a typical medication management system includes a point of care computer, such as a barcode point of care computer and/or pharmacy computer, and/or an MMU, in communication with one or more medication delivery devices. The point of care computer(s) and/or the MMU, with associated memory, store and share or communicate various information, such as patient information, prescription information, customized drug library or other information, for managing medication delivery to a patients, such as performing five-rights checking, configuring the medication delivery devices, and receiving and storing event, status or activity information received from the medication delivery devices.
Caregivers and clinicians use outputs from patient monitoring and equipment monitoring devices to make various patient care decisions. Patient monitoring devices and patient care equipment monitoring devices may be connected to a receiver, which receives the output signals from the patient monitoring devices and patient care equipment monitoring devices. In some cases, the receivers may display and/or record the information from the patient and patient care equipment monitoring devices. In other cases, the devices may include a monitor and/or recording medium. The receivers or devices may also have preset or adjustable alarms that are triggered when one of the outputs from the patient or patient care equipment monitoring devices deviates from a pre-set limit.
In hospitals that use infusion pumps and other medical devices, alarms are used to indicate device malfunction, therapy interruptions, end of therapy and other events that need to be handled by the clinical staff. Typically, alarms get displayed on device screens and produce audible sound. In some cases, there are too many devices that alarm in close proximity to each other. As a result, it is very hard to tell which device is actually alarming. The sound of alarms can also disturb or wake up sleeping patients. Hospital nurses usually manage multiple infusions running on multiple patients in one or more given clinical care areas. It is difficult for a nurse to be in the same vicinity of the infusion device at all times during an infusion, thus making it difficult to respond immediately to infusion-related or infusion device alarms. Further, clinical staff is not always in the close proximity to the alarming device to hear the alarm. In such situations it would be desirable for the staff to be notified of device alarms as soon as possible regardless of their proximity to the device so that they can better attend to their patients' needs.
Further, in some patient cases, it is critical to isolate the patient and reduce the exposure of the patient to unnecessary hospital conditions (e.g. burn patient being exposed to drafts or airborne contaminants when opening the door to the patient room). Further, multiple nurses may utilize the same pump on a patient between device cleaning. This results in an increase possibility of contamination due to an increased number of clinicians contacting the device. The pump may be contaminated by a clinician. This contamination may be transferred to the patient either by the clinician that first contaminated the pump or by a subsequent clinician who acquires the contamination by contacting the pump and then who transfers the contamination to the patient in the course of providing care to the patient. Further, contamination applied to a pump may be transferred to other devices and patients by clinicians who come in contact with the contamination on the pump and carry it with them to other pumps and patients where the contamination can be deposited and spread. Where alarms require a clinician to actually come to and contact a pump in order to assess the alarm, shut the alarm off or otherwise respond to the alarm, the likelihood of such contamination and cross-contamination increases.
A patient care system is disclosed that, in a preferred embodiment, includes at least one medical device such as an infusion pump. Each pump is capable of generating a data message containing information regarding the pump including the status of the therapy being delivered, operating data or both. The patient care system includes an alarm generating system that received the data message from the pump. The alarm generating system assesses the data message from the pump and fires a trigger if certain conditions established by a first set of rules, algorithms or instructions are met. The firing of a trigger produces an alarm message. This alarm message is assessed according to a second set of rules, algorithms or instructions as to whether to suppress the alarm message. For both the first and second algorithms, information generated by each pump is a required input.
The patient care system also includes a dispatching system that is connected to the alarm generating system. The dispatching system is adapted to forward the alarm message to an alarm destination according to a third set of rules, algorithms or instructions. Further, the patient care system includes an alarm destination connected to the dispatching system, the alarm destination expressing an alarm upon receipt by the alarm destination of the alarm.
In an alternate embodiment of the patient care system, the medical device is not part of the patient care system. Instead, the patient care system as disclosed interacts with the medical device. In another alternate embodiment of the patient care system, then alarm destination is not part of the patient care system but instead interacts with the patient care system. In yet another alternate embodiment of the patient care system, both the medical device and alarm destination are not part of the patient care system but instead interact with the patient care system. In yet another embodiment of the patient care system, both including and excluding the medical device and alarm destination or both, the alarm generating system and the dispatching system are combined into a single system.
Referring to the Figures, a patient care system is shown in the Figures generally referred to by the reference number 10. The patient care system 10 interacts with a medical device 12 to manage alarms produced by the medical device 12. The patient care system 10 includes a dispatching system 14, an alarm forwarding system 16 and, in certain embodiments, a monitor/controlling system 18.
The patient care system 10 is intended to be deployed in any hospital or other facility that utilizes medical devices 12, including but not limited to infusion pumps, that are connected to networks either via hardwiring or through wireless connections. Such networks may be specific to the connection of one or more pumps 12 to each other or to control or monitoring devices. The networks may connect many medical devices and allow control or monitoring of a variety of such devices including control or monitoring from and to remote locations.
Medical device 12 is preferably an infusion pump 12 capable of receiving programming data from a nurse or other practitioner. Further, pump 12 is preferably capable of having its operational infusion program reviewed or confirmed or both by the nurse or other practitioner. Examples of pump 12 are the PLUM A+™ infusion system, LIFECARE PCA™ infusion system and SAPPHIRE™ infusion system sold by Hospira, Inc. of Lake Forest, Ill. Although medical device 12 is preferably an infusion pump 12, pump 12 as applied to the present patient care system 10 is intended to be understood to be any medical pump and more broadly, any medical device that has the capability of producing data and being connectable to a dispatching system 14 as described herein. Each pump 12 or other medical device is capable of generating a data message containing information regarding the pump including the status of the therapy being delivered, operating data or both. Examples of the data message generated by the pump 12 include, but are not limited to, pump 12 status data, the status of the therapy being delivered by the pump 12, event data associated with the pump 12 (e.g., expiration of certain time periods) and alarms associated with pump 12 or the delivery of therapy by the pump 12. Further, in some embodiments, pump 12 includes a local delay timer 50. The local delay timer may be a mechanical timer or a timer implemented in software. The local delay timer 50 is activated and begins counting when an alarm condition message is sent by the pump 12 to the dispatching system 14. In other embodiments of pump 12, pump 12 includes logic 52 that can be either discrete or implemented through software. Logic 52 allows pump 12 to make evaluations or take actions according to programming including rules, algorithms or instructions implemented on or associated with the logic 52 and may, in certain embodiments, also provide the local delay timer 50.
Dispatching system 14 is preferably a network application that manages alarms and preferably includes a dispatching server 20 capable of running software. A key function of the dispatching system 14 is to facilitate alarm management from the pump 12 to one of more alarm destinations (e.g., monitor/controlling systems 18) and back. For example, in a preferred embodiment, the dispatching system 14 is adapted to forward the alarm messages from the pump 12 to one or more monitor/controlling systems 18 according to a set of rules, algorithms or instructions. In a preferred embodiment of the patient care system 10, these rules, algorithms or instructions are executed on the alarm forwarding system 16 which, in effect, orchestrates the alarm flow from the pump 12 to one or more monitor/controlling systems 18 and back in order to implement safe, secure and reliable alarm handling. In a variant of this embodiment, rules, algorithms or instructions may be implemented on the pump 12 itself. The rules, algorithms or instructions can be configured by a rule editor.
In one embodiment, the dispatching server 14 incorporates an alarm forwarding system 16 that separates the alarm communication from the actual means of communication and forwards alarm information to monitor/controlling systems 18 according to rules, algorithms or instructions. The alarm forwarding system 16 assesses data messages produced by the pump 12 that are passed from the pump 12 to the alarm forwarding system 16 by the dispatching system 14 and fires a trigger if certain conditions established by a first set of rules, algorithms or instructions are met. The firing of a trigger produces an alarm message that is assessed according to a second set of rules, algorithms or instructions as to whether to suppress the alarm message. An example of a dispatching server 14 is a server equipped with the Hospira MedNet™ medication management software manufactured and sold by Hospira, Inc. of Lake Forest, Ill. The dispatching server can be used in combination with a hospital's existing alarm forwarding system or can be used in combination with a hospital's alarm forwarding system that has been modified to interface with the alarm messages received from dispatching server 14. In a preferred embodiment of the patient care system 10, the dispatching system 14 and alarm forwarding system 16 are separate systems that are connected together, for example, by a local area network (LAN) or wide area network (WAN), whether wireless, hardwired or connected by optical fibers, or any other communication protocol or system. However, the dispatching system 14 and alarm forwarding system 16 can be combined into a single system that performs the functions of the dispatching system 14 and alarm forwarding system 16 as described herein.
The patient care system 10, in a preferred embodiment, includes one or more monitor/controlling systems 18 connected to the dispatching system 14. The function of the monitor/controlling system 18 is to connect to the dispatching system 14, receive alarms and data from the dispatching system 14, communicate such alarms and data to a clinician and, in some embodiments, allow a clinician to produce a response to such alarms and data and otherwise produce acknowledgment or control responses and communicate such responses and acknowledgments to the dispatching system 14. The monitor/controlling system 18 preferably expresses an alarm upon receipt by the monitor/controlling system 18 of an alarm notification. The alarm can take various forms, including but not limited to an audible, visual, or vibratory alarm. The list of possible monitor/controlling systems 18 includes, but is not limited to, mobile wireless devices, network connected workstations, laptop computers, tablets, electronic mail, text messages, pagers and even fax machines
In an embodiment of the patient care system 10, medical device 12 forwards a data message to dispatching system 14, and dispatching system 14 accesses the data message to determine if an alarm condition is met and if an escalated alarm should be suppressed. For example, a local alarm at the medical device 12 could be temporarily suppressed while an alarm is sent to a remote monitor/controlling system 18. The content of the data message could be a required input for the evaluation of both whether or not an alarm condition is met, and if the escalated alarm should be suppressed. As mentioned above, the data message could contain information regarding pump therapy status data, pump operating point data, or both pump therapy status data and pump operating point data. If an alarm condition is met, dispatching system 14 could cause alarm forwarding system 16 to forward an alarm message to one or more monitor/control systems 18. As a result, the monitor/controlling system 18 does not sound the alarm at the monitor/controlling system 18 except under certain predetermined conditions. Further, the medical device 12 itself may not sound an alarm except according to certain predetermined conditions.
Although the patient care system 10 described herein interacts with one or more pumps 12, the pumps 12 are not required to be part of the patient care system 10. However, as described hereafter, various aspects of the functionality of the patient care system 10 may be shared with the pump 12 so that in some embodiments the pump 12 may be part of the patient care system 10.
Besides receiving data from a pump 12, the dispatching system 14 may also send programming data to the pump 12. Such programming data may reconfigure the parameters and operation of the pump 12 with respect to both infusing of medication by the pump 12 and the type, amount and frequency of data gathered by the pump 12 and sent to the dispatching system 14. Further, dispatching system 14 may also send drug library data to the pump 12 which may then be used by pump 12 to configure limits and infuser settings to be used in the infusion of medication to the patient. In addition, the dispatching system 14 may send software updates to the pump 12 so that pump 12 has the most current software for its operations.
Dispatching system 14 interacts with alarm forwarding system 16 to forward alarms generated by the dispatching system 14 according to the appropriate recipient according to rules, algorithms or instructions. These rules, algorithms or instructions can, in part, be based on or take into consideration the clinical care area (CCA), patient identification, alarm priority, location of the pump 12 and the type of drug being infused by the pump 12. The rules, algorithms or instructions can be fixed and predetermined or can be customizable by the hospital or healthcare facility according to their own preferred practice or other practices recommended by others. An example of an appropriate recipient is the nurse who is caring for a patient that is receiving therapy from a pump 12. Further, where the alarms are sent to appropriate recipients, who that recipient is or the location where the alarm was forwarded may also be indicated or displayed on the pump 12 itself.
Dispatching system 14 may also communicate data, raw or processed by the dispatching system 14, to a clinical system 24 through an interface 22. Interface 22 provides a connection between the dispatching system 14 and a clinical system 24. The clinical system 24 may be another network (separate or interconnected with the network of dispatching system 14) where such network communicates information to the appropriate recipients such as the nurse having supervisory responsibility for the nurse caring for a patient that is receiving therapy from a pump 12, a physician overseeing the care of the patient, a pharmacist preparing medication for the patient or any combination of these or others having a need to know the status of the infusion therapy being applied to a patient through a pump 12. Examples of the data that can be communicated from the dispatching system 14 to and from the clinical system 24 via the interface 22 and from the clinical system 24 to an appropriate recipient includes, but is not limited to, the raw data produced by the pump 12 such as pump status data, pump event data and alarms associated with pump 12 or rules, results and data that has been processed by the dispatching system 14 or alarm forwarding system 16.
Further, the clinical system 24 allows appropriate personnel, such as the physician overseeing the care of the patient, to interface with and ultimately control or change the operation of the pump 12. For example, a physician through the clinical system 24 could modify the infusion parameters of the pump 12 by sending an infusion order to the clinical system 24 that passes through the interface 22, dispatching system 14 and ultimately to the pump 12. Further, new or modified programming data for the pump 12 may be entered into the clinical system 24, passed through the interface 22 to the dispatching system 14 and ultimately to the pump 12 where the current programming of pump 12 is either modified or replaced, preferably in an automated and/or remote manner.
Interface 22 likewise allows appropriate personnel to administer the rules used to control alarm forwarding in the system via a rule editor available on monitor/control device 18 or clinical system 24. The administration interface would allow the hospital personnel to determine rules for what contents from a data message from pump 12 would cause an alarm message to be generated. For example, an administrator could determine that an alarm would be generated whenever a certain kind of medication was interrupted, even if only temporarily, while the interruption of a different kind of medication did not generate an alarm unless the interruption was of a sufficient duration. The administration interface could also allow the hospital personnel to determine rules for what contents from a data message from pump 12 would control how and if certain alarm messages would be suppressed. For example, an administrator could determine that an alarm message generated based on a data message regarding a life critical or otherwise high risk drug, such as analgesics, sedatives or anticoagulants like Heparin for example, would not be suppressed at all, an alarm message generated based on a data message regarding a less critical drug could be locally suppressed at the device but could not be cleared remotely, and an alarm message generated based on a data message regarding a noncritical drug could be both locally suppressed at the device and cleared remotely.
An example of how information flows in patient care system 10 can be described with references to
The administration interface could also be used to control how certain alarm messages flowed in patient care system 10. For example, the rules applied to alarm messages by alarm forwarding system 16 could be configurable so that alarm messages pertaining to life critical drugs were forwarded to various monitor/controlling systems 18 in parallel while alarm messages pertaining to less critical drugs were forwarded to a single monitoring system 18 and serially forwarded to another monitoring system 18 only in the event that the alarm was not acknowledged.
As can also be seen, the dispatching system 14 may receive an acknowledgment message 27 from the appropriate personnel, in this case, the nurse. Upon receipt of an alarm message, the nurse may send an acknowledgment message acknowledging receipt of the alarm message. Once again, the rules, algorithms or instructions 25 operating on dispatching system 14 for this alarm condition processes the acknowledgment and determines if additional action needs to be taken. For example, if an acknowledgment message is not received within a predetermined time, the algorithm could instruct the pump 12 to issue a local alarm to alert those caring for the patient in the vicinity of the patient of this alarm condition. Of course, if the alarm condition is acknowledged before the predetermined time has expired 29, no such local alarm may be required as defined by the algorithm 25 and thus no local alarm will sound by pump 12.
In embodiments of patient care system 10 where an alarm condition has been forwarded to the dispatching system 14, it is desirable, but not required, to indicate on the pump 12 that an alarm occurred and that it has been forwarded. Further, in situations where the local alarm is suppressed, it is desirable, but not required, that the time remaining before the alarm sounds or is otherwise indicated locally on the pump 12 be displayed so that the clinician located in the vicinity of pump 12 may see and act upon this information appropriately.
Further, a desirable function of the patient care system 10 is the capability to have confirmation that an alarm has been successfully delivered. As shown in
Each combination of alarm forwarding, acknowledgment, and particular kinds of suppression can be referred to as a suppression protocol. For example, the combination of suppressing a local auditory alarm until either a set time has elapsed or an alarm forwarding confirmation or acknowledgment was received is a first suppression protocol, while the combination of suppressing a remote alarm to a supervisor until either a set time has elapsed or a primary care giver cleared an alarm locally at the medical device is a second suppression protocol. Various suppression protocols can be created by hospital personnel via use of the rules editor mentioned previously, which can in one embodiment be incorporated into the Hospira MedNet™ software. The various suppression protocols can further be selectively applied by the care system based on the content of medical device data messages, alarm messages, and other information available to the system. As such, particularly stringent suppression protocols can be applied to low priority alarms automatically while more lax suppression protocols are applied to higher priority alarms.
In all of the above situations in which the content of a data message from pump 12 or the content of an alarm message were used to control the manner in which an alarm was generated, suppressed, or forwarded, the clinical care area (CCA) of the pump or medical device 12 can be used additionally or in the alternative as an input to a rule or can be used to select which rule should to be applied. This functionality provides significant benefits in that an alarm forwarding protocol or alarm suppression protocol might be appropriate for a given medical situation in one CCA and not appropriate in another. For example, the temporary interruption of a basic saline drip may be a low priority alarm towards which a stringent suppression protocol is applied in one CCA while the same medical event is a high priority in a level 4 NICU where the slightest divergence from a planned treatment can be more problematic for the patient. The CCA can be received as an input for any of these determinations by first being programmed into the medical device when it is deployed or provided in a drug library downloaded to the medical device, and subsequently selected by the clinician on the device so that the selected CCA information is delivered as part of the data message generated by the medical device 12. In the alternative, the CCA can be determined indirectly from the data message and/or alarm message by conducting a lookup operation on a database associated with a server that is in communication with a plurality of the medical devices in the healthcare facility. For example, an ID number associated with a pump could be received in a data message and then applied to a database to lookup the CCA area in which the pump had last been deployed, programmed in, or heard from via the network.
In this example, if an alarm condition occurs at 26, the pump 12 generates an alarm condition message at 28. This alarm condition message is sent from pump 12 to the dispatching system 14 where the alarm condition message is evaluated at 30. The alarm condition message preferably includes information relevant to the alarm such as pump 12 ID, the patient ID/name, location of pump 12 and type/concentration/name of drug used. Pump 12 gets acknowledgement from the server of the dispatching system 14 that it received the alarm and acknowledgement from the forwarding system 16 and/or the alarm destination or recipient entity.
The evaluation at 30 occurs according to rules, algorithms or instructions established in the dispatching system 14. If, at step 30, it is determined that the alarm condition received from pump 12 should be passed to the alarm forwarding system 16 to be managed, the alarm condition is passed to the alarm forwarding system 16 where it is received at step 32. Alarm forwarding system 16 then forwards the alarm condition to the appropriate personnel via monitor/controlling systems 18 according to the rules, algorithms or instructions established in alarm forwarding system 16 for that particular alarm condition. Alarms have different priorities and repeat rates and require different responses. As a result, the rules, algorithms or instructions established in alarm forwarding system 16 determine which alarms get priority when one or more alarms are present at the same time as well as the appropriate routing, timing and display of alarm information in alarm conflicts. Further, the rules, algorithms or instructions established in alarm forwarding system 16 determine how, when and by whom alarms may be cancelled or suppressed, particularly in alarm conflict situations.
The monitor/controlling system 18 to which the alarm forwarding system 16 forwards the alarm condition may be any of a number of devices such as a pager, mobile phone, wireless device, tablet, workstation, email or any other form of communication that is able to communicate with the alarm forwarding system 16 and communicate information to the appropriate personnel. In the embodiment shown, the dispatching system 14 itself evaluates, according to rules, algorithms or instructions established in the dispatching system 14, whether the alarm condition received from pump 12 should be passed to the alarm forwarding system 16 to be managed. In an alternate embodiment, the dispatching system 14 contains no such evaluation system but instead passes the alarm message directly to the alarm forwarding system 16.
Upon receipt of an alarm condition message by the alarm forwarding system 16 at 32, in the embodiment shown, the program passes to step 34 where it is determined whether the alarm forwarding system 16 is configured to send a “successfully received” acknowledgment of the alarm condition message. If the alarm forwarding system 16 is so configured, the program passes from step 34 to step 36 where a “successfully received” acknowledgment message is generated and sent from the alarm forwarding system 16 to the dispatching system 14.
The “successfully received” message sent from alarm forwarding system 16 is received at the dispatching system 14 at step 38. Step 38 determines whether the alarm condition message originally generated by pump 12 and passed to dispatching system 14 was successfully forwarded to the alarm forwarding system 16. If, according to the logical operations of this step 38, the alarm condition message was not received by the alarm forwarding system 16, the program passes to step 40 where an escalation scheme is entered. The escalation scheme includes a determination, by rules, algorithms or instructions, of the appropriate response when an alarm condition message has not been acknowledged. Examples of such an appropriate response could be resending the alarm condition message, sending the alarm condition message to another monitor/controlling system 18, triggering a local display of the alarm condition on the pump 12, causing the display of an alarm alert condition at some other device, or any other appropriate response as determined by those having care of the patient and which have been programmed into the rules, algorithms or instructions operating on the dispatching system 14.
If the alarm condition message generated by pump 12 was ultimately received by the alarm forwarding system 16, then at step 38 a confirmation message is automatically sent to both steps 42 and 44 which are processed on the pump 12 by the operation of the logic 52 as explained above. At step 42, whether the alarm condition message was successfully forwarded to alarm forwarding system 16 is evaluated. If the alarm condition message was not successfully forwarded to the alarm forwarding system 16, the program passes to step 46 where a local alarm is visually displayed. If however, it is ascertained at step 42 that the alarm condition was successfully received by the alarm forwarding system 16, the program passes to step 48 where no local alarm is displayed by pump 12.
In this embodiment, pump 12 includes a local delay timer 50 as described above. Such a local delay timer 50 is activated when an alarm condition message is sent at step 28 by the pump 12 to the dispatching system 14. As mentioned, at step 38 the dispatching system 14 determines whether the alarm condition message generated by pump 12 was received by the alarm forwarding system 16. If the alarm condition message was ultimately received by the alarm forwarding system 16, the program also passes to step 44. Step 44 determines whether to cause the local delay timer 50 to cease. This determination at step 44 occurs according to rules, algorithms or instructions. In particular, this determination preferably takes into consideration whether an acknowledgment of receipt of an alarm message 54 has been sent by medical personnel at 58 and ultimately passed through steps 60 and 62 to step 54 where an acknowledgment message is sent from step 54 to step 44. Logic 52 (
Receipt at the monitor/controlling system 18 of an alarm condition causes the monitor/controlling system 18 to display the alarm condition at 56. This display may take the form of visual, audible or tactile displays. For example, the display may cause an audible alarm to sound indicating to the clinician the receipt of an alarm condition message. Further, the display may, on a viewing screen, display information related to the alarm condition message. In addition, the display may include activation of a visual indicator of the receipt of an alarm condition message such as a flashing light. Finally, the display may take the form of a tactile display such as a vibrating device indicating to the clinician the receipt of an alarm condition message. This list of possible displays is intended to illustrate possible displays or indications that a monitor/controlling system 18 may use. However, it is to be understood that this list is illustrative and not intended to be limiting. As a result, it is intended that any type of display that attracts the attention of the clinician to the receipt of an alarm condition message or displays or otherwise communicates the contents of an alarm condition message is intended to be within the scope of the present patient care system 10.
Upon receipt of an alarm condition message by a monitor/controlling system 18, the clinician may send an “acknowledgment of receipt” message back to the dispatching system 14 if their destination device permits two-way communication. Generating and sending such an acknowledgment message occurs at the monitor/controlling system 18 at 58. The acknowledgment receipt message is sent from the monitor/controlling system 18 to the alarm forwarding system 16 at 60 where the acknowledgment of the receipt of the alarm condition message is passed to the dispatching system 14 at 62. Step 62 determines whether the alarm message 28 previously sent from the dispatching system 14 has been acknowledged. If it has not, the program passes to 40 where an escalation scheme is determined according to rules, algorithms or instructions.
If, at step 62, it has been determined that an alarm condition acknowledgment message has been received, the program passes to step 54 where acknowledgment message is sent from the dispatching system 14 to the pump 12 at 44. This alarm condition 28 is evaluated at 64 to determine, according to rules, algorithms or instructions, if this alarm condition requires the display of a local alarm on pump 12. Whether such an alarm condition 28 requires the display of a local alarm on pump 12 is determined according to certain rules, algorithms or instructions that have been programmed into the pump 12. If the alarm condition 28 requires that a local alarm be displayed on pump 12, such an alarm is displayed at 46. If the alarm condition 28 does not require that a local alarm be displayed, the program advances to 42 where it is evaluated whether the alarm condition was successfully forwarded to appropriate personnel through the dispatching system 14 and alarm forwarding system 16.
The creation of an alarm condition at 26, in addition to the sending of an alarm condition message at step 28, also causes the program operating according to the logic 52 on pump 12 to move to step 66 where it is determined, according to rules, algorithms or instructions, whether pump 12 is configured to suppress the local alarm audio alarm. Determining whether pump 12 is configured to express the local alarm audio alarm is done according to rules, algorithms or instructions programmed on the pump 12.
If, at step 66, it is determined, according to rules, algorithms or instructions, that the pump 12 is configured to suppress the local audio alarm, the program advances to step 68 where it is evaluated whether to delay or suppress the local audio alarm based on its rules, algorithms or instructions including, but not limited to, reference to the current stage of the local delay timer 50. If, at step 68, it is determined that the local audio alarm should be suppressed, the program passes to step 70. Step 70 determines whether the local delay timer 50 has exhausted its predetermined delay time and the alarm condition still persists. If the local delay timer 50 has exhausted its local delay time and the alarm condition still persists, the program passes to step 72 where pump 12 provides a local audio alarm even though the alarm had previously been determined to be suppressed. The reason the alarm suppression is overridden in this embodiment is that the failure to receive an acknowledgment of receipt of an alarm notice, as evidenced by the local delay time 50 timing out, has been determined, according to rules, algorithms or instructions, to require an alarm to be generated. Also, according to rules, algorithms or instructions, the alarm can be generated immediately or can be generated after taking further action (e.g., resending the alarm message to see if an acknowledgment or receipt of the alarm message returns). If at step 66 it is determined that pump 12 is not configured to suppress a local audio alarm indication, the program passes to step 72 where pump 12 provides a local audio alarm. Either or both a local audio or visual alarm can be produced at 46 and 72.
Although embodiments of the patient care system 10 discussed above had the alarm forwarding system 16 sending a “successfully received” acknowledgment of the alarm condition message, this is not required for the patient care system 10. Further, although those embodiments of the patient care system 10 had an escalation scheme 40, that also is not required for the patient care system 10. Similarly, various explicit acts, evaluations, messages sent or suppressed, alarms activated or suppressed and similar aspect of the embodiment described above and with respect to other embodiments shown may be eliminated or added in a wide variety of permutations and combinations and still fall within the scope of the invention. Patient care system 10 allows for the management of alarms in all varieties of the term “management.” The various aspects of “managing” alarms given in this description are intended to be illustrative and not limiting.
Where an administrator desires to reconfigure a pump 12, the monitor/controller system 18 “pings” the alarm forwarding system 16 at 78 to determine which pumps 12 are available for configuration. The alarm forwarding system 16 then “pings” the dispatching system 14 at 80 to determine which pumps 12 are available for configuration. The pumps 12 in communication with dispatching system 14 send their identification information and data to dispatching system 14 at 82. This can be a near real time push of data from the pumps 12 to the dispatching system 14 or the data can be pulled in response to a request or “ping” of the pumps by the dispatching system 14. Dispatching system 14 then sends information about the available pumps 12 to the alarm forwarding system 1610 at 84 where such information is sent to the monitor/controller system 18 at 86 where the monitor/controller 18 displays the relevant information about this particular pump 12 including the current status of the pump and the range of available options for reconfiguration. By monitor/controlling system 18 displaying this information, the information is made available to the administrator.
Once the administrator has determined which pumps 12 are available for configuration, the administrator selects the pump 12 to be configured at 88. The administrator makes the desired selection on the monitor/controller system 18 which then displays the newly configured settings about this particular pump 12 at 90. Once the administrator has entered the particular parameters for configuration of the desired pump 12 on the monitor/controlling system 18, the monitor/controller system 18 passes this information to the alarm forwarding system 16 at 92 which sends the information to the dispatching system 14 at 93 where the parameters configuration are sent to the selected pump 12 by the dispatching system 14 where they are received by the pump 12 at 94 and implemented on the pump 12 at 95.
A similar process is employed for the administrator to configure the dispatching system 14, alarm forwarding system 16 or the monitor/controller system 18 itself. If the monitor/controller system 18 itself is to be configured, the configuration can take place directly by entering the new configurations on the monitor/controlling system 18. However, it may be desirable to alert others through the dispatching system 14 or clinical system 24 of such configuration changes. In that case, the monitor/controller system 18 sends the configuration information to the alarm forwarding system 16 which sends this information to the dispatching system 14 which then sends the information, according to rules, algorithms or instructions on the dispatching system 14, to the appropriate locations.
Where the alarm forwarding system 16 is to receive new configurations, configurable aspects of the alarm forwarding system 16 are displayed on the monitor/controller system 18. The desired configurations for the alarm forwarding system 16 are entered into the monitor/controlling system 18 which then sends the new configurations to the alarm forwarding system 16 to be implemented. Again, it may be desirable to alert others through the dispatching system 14 or clinical system 24 of such configuration changes. In that case, the alarm forwarding system 16 sends the configuration information to the dispatching system 14 which then sends the information, according to rules, algorithms or instructions on the dispatching system 14, to the appropriate locations.
Where the dispatching system 14 is to receive new configurations, configurable aspects of the dispatching system 14 and alarm forwarding system 16 are received from the dispatching system 14, passed through the alarm forwarding system and displayed on the monitor/controller system 18. The desired configurations for the dispatching system 14 are entered into the monitor/controlling system 18 which then sends the new configurations to be implemented by the dispatching system 14. Again, it may be desirable to alert others through the dispatching system 14 or clinical system 24 of such configuration changes. In that case, the dispatching system 14 sends the information, according to rules, algorithms or instructions on the dispatching system 14, to the appropriate locations.
In this embodiment, the interface 22 and clinical system 24 are not explicitly shown. However, the interface 22 and clinical system 24 may be incorporated into a monitor/controller system 18. However, it is to be understood that interface 22 and clinical system 24 may be separate and independent systems or that the functions of interface 22 and clinical system 24, in whole or in part, may be performed by the dispatching system 14, alarm forwarding system 16 or monitor/controlling system 18. Further, it is within the scope of the patient care system 10 that the function or elements or both of the dispatching system 14, alarm forwarding system 16, interface 22, clinical system 14 and monitor/controlling system 18 be combined in any permutation or combination of such functions or elements including into a single system.
The operation of the patient care system 10 with respect to the alarm forwarding function is shown in
As mentioned above, when an alarm condition is generated at 26 and the pump 12 is connected to the dispatching system 14, an alarm condition message is sent at step 100 to the dispatching system 14 where it is received at step 102. At step 102, the alarm condition message is evaluated according to the rules, algorithms or instructions that determine whether the alarm condition message should be forwarded to the alarm forwarding system 16 or the monitor/controller system 18 or both. If, at step 102, it is determined that the alarm condition message should not be forwarded to either the alarm forwarding system 16 or monitor/controller system 18, the program passes to step 98 where the pump 12 will display or generate an alarm on the pump 12.
If, at step 102, it is determined that the alarm condition message should be forwarded to either the alarm forwarding system 16 or monitor/controller system 18, the program passes to step 110 in the alarm forwarding system 16. At step 110, the program determines, according to rules, algorithms or instructions, whether the alarm condition should be routed to a recipient and if so, which recipient. If it is determined that the alarm condition notice should be forwarded to a recipient, the program passes from step 110 in the alarm forwarding system 16 to step 112 in the monitor/controller system 18. In order for the program to reach step 110, an alarm condition message must have been received by the alarm forwarding system 16. Consequently, at step 110, the program passes to step 114 where it is determined whether the alarm forwarding system 16 is configured to send acknowledgment of a successful receipt of an alarm notice message. If the alarm forwarding system 16 is not configured to send such an acknowledgment, the program passes to 116 were no further action is taken. However, if the alarm forwarding system 16 is configured to send such an acknowledgement, the program passes to step 118 where such acknowledgment is generated by the alarm forwarding system 16 and sent to the dispatching system 14 to be received at step 120. If, at step 120, it is determined that the alarm condition message was successfully received by the alarm forwarding system 16, the program passes to step 108 in the pump 12.
If, at step 108, it is determined that the alarm condition message generated at step 100 was not received by the alarm forwarding system 16, the program passes to step 106 where an alarm condition indicating that the alarm condition message was not received by the alarm forwarding system 16 is displayed on the pump 12. If however, at step 108, it is determined that the alarm condition message generated step 100 was successfully received by the alarm forwarding system 16, the program passes to step 122 where no alarm is displayed locally on pump 12.
If, at step 120, it is determined that the alarm condition message received from pump 12 by the dispatching system 14 at step 102 has not been successfully forwarded to the alarm forwarding system 16, the program passes to an escalation scheme 40 where the appropriate level of escalation is determined according to rules, algorithms or instructions as discussed above. Also at step 120, if it is been determined that the alarm condition message generated by pump 12 and received by dispatching system 14 has also been successfully received by the alarm forwarding system 16, the program also passes to step 44 where the local delay timer 50 is canceled and no alarm message is generated.
If, in the monitor/controller system 18 at step 112, an alarm condition indication is indicated on a monitor/controlling system 18, the program passes to step 124 where the recipient of the alarm condition message is given the opportunity to acknowledge receipt of the alarm condition message. If the recipient chooses to generate an acknowledgment of the receipt of such a message, the program passes to step 126 in the alarm forwarding system 16 where the acknowledgement is passed to step 128 in the dispatching system 14. Step 128 ascertains whether the recipient has acknowledged receipt of the alarm condition message sent by pump 12. If the answer is yes, the program passes to step 130 where acknowledgment to send from the dispatching system 14 to step 44 where the local delay timer 50 is canceled and no alarm message is thus generated.
If an alarm condition indication is sent to a monitor/controlling system 18 at step 112, the program passes to step 132 where, according to rules, algorithms or instructions, it is ascertained whether the alarm condition is capable of remote clearing. If the alarm condition is not capable of remote clearing, the program passes to step 134 where no further action is taken. However, if the alarm condition is capable of remote clearing, the program passes to step 136 where the alarm may be cleared on the monitor/controlling system 18 by a qualified clinician.
The program then passes to step 138 in the alarm forwarding system 16. Step 138 passes the alarm clearing message to step 140 of the dispatching system 14 which passes the alarm clearing message to pump 12 at step 142. At step 142, the pump alarm is cleared on pump 12. If the pump alarm is cleared at step 142 on pump 12, the program passes to step 144 of the dispatching system 14. At step 144 the dispatching system 14 is notified that the alarm condition message previously generated by pump 12 at step 100 has been cleared remotely. The program then passes to step 146 on the alarm forwarding system 16 where a local alarm notification is sent to the appropriate recipients as determined by the rules, algorithms or instructions running on alarm forming system 16. Further, the program passes to step 148 in the monitor/controller system 18 where a local alarm condition is indicated on the appropriate monitor/controlling systems 18 indicating that an alarm condition notice has been cleared.
The program then passes to step 150 where it is determined whether the alarm condition has been resolved. If the alarm condition has been resolved, the program passes to step 152 on pump 12 where the alarm on pump 12 is cleared. If the program determined at step 150 that the alarm condition is not been resolved, the program passes to step 40 where an escalation scheme is entered into so that the appropriate action, according to the rules, algorithms or instructions previously determined, can be taken to resolve the alarm condition issue. At step 144, the program also passes to step 72 where, as described above, if the pump 12 is not configured to suppress a local edible alarm, pump 12 will provide a local audible alarm.
When an alarm gets cleared, either manually by a clinician or automatically according to the rules, algorithms or instructions running on the patient care system 10, a “clearing alarm message” may be sent to all the entities that received the original alarm. Such clearing alarm message may indicate how the alarm was cleared, when, and by whom and may include an indication of what the original alarm was, its timestamp and how the alarm was resolved. Further, although the alarm has been shown as being cleared in certain locations, the alarm may be cleared from wherever a clinician has access to the patient care system 10, whether at the pump 12, dispatching system 14, alarm forwarding system 16, clinical system server 24 or monitor/controlling system 18. It may be desirable to explicitly indicate or highlight on the pump 12 itself that the clearing took place remotely in order to alert the nearby attending personnel of the source of the clearing. In addition, if the alarm is locally cleared before it was cleared remotely, the dispatching system server 14 will receive notice of this occurrence and forward such notice to the remote recipients.
Further, it is desirable if the alarm is cleared remotely but not locally, that the local delay timer described above be employed to re-start the alarm sequence described herein after the expiration of a predetermined time in case a clinician clears the alarm remotely but forgets to check on the pump 12 and clear the alarm locally on the pump.
As can be seen in the description of the patient care system 10, there are certain steps that are performed as part of the logic, whether software or by discrete logic on the various components of the patient care system 10 and pump 12. But, there are also certain steps that are performed by the clinician that are not part of or performed by such logic. Where a process involving the patient care system 10 involves steps performed by the clinician but that are not performed by the patient care system 10, whether in embodiments including the pump 12 or monitor/controller 18, the process steps performed by the clinician are not part of the patient care system 10.
Also as shown in
Another management function of the patient care system 10 is shown in
The process passes to step 182 where the monitor/controller 18 for the person passing responsibility for the pumps 12 then transfers the list of selected pumps 12 to the monitor/controlling system 18 of the person receiving responsibility for the pumps 12 via the alarm forwarding system 16 where this information is received at 184. At step 184, the alarm forwarding system 16 pushes the list of selected pumps to the selected monitor/controller 18 receiving responsibility for the pumps 12 at 186. At 186, the respective monitor/controlling system 18 displays the transferred list of pumps 12 and ask for confirmation of the transfer. The clinician associated with the new responsibility for the pumps 12 then, on their monitor/controlling system 18, accepts the pump list transfer at 188. Also, as a result of the clinician accepting the pump 12 transfer list, the monitor/controller 18 of that clinician then displays the list of newly acquired pumps 12 at 190.
A monitor infusion function of the patient care system 10 is displayed in
The patient care system 10 may also include functionality that affects the duration that certain information is displayed on the monitor/controller system 18. An example of such functionality is shown in
As a result of having transferred responsibility for one or more pumps 12 to another monitor/controlling system 18, the clinician may clear their monitor/controlling system 18 of the transferred pumps 12. Of course, the clinician must first have transferred responsibility for the pumps 12 as is done at step 208 where the process described above is summarized into a single step 208. Thereafter, the program passes to 210 where the clinician clears the pumps 12 that have been transferred. The program then passes to step 212 where the monitor/controlling system 18 clears the previously monitored pumps 12 which have now been transferred to another clinician.
As shown in part C of
Further, the order of display of the pumps 12 being monitored can be changed to represent the priority of their respective statuses. For example, as shown in part C of
Throughout this description, repeated mention has been made to “rules, algorithms or instructions.” These rules, algorithms or instructions can be directed to virtually anything that is determined to be useful including, but not limited to, promoting safety or improving efficacy, longevity or ease of use. In addition, where the clinician is configuring or reconfiguring a pump 12, these rules, algorithms or instructions can include safeguards to warn clinicians if certain configurations are outside of accepted bounds or are dangerous so that the clinician may be required to confirm such configurations before they are accepted by the patient care system 10. Further, where, when and to whom alarm messages may be forwarded or communicated to may take into consideration the staff available, clinical care area (CCA), therapy being delivered, type of drug, condition of the patient, time of day, day of the week, whether there has been or is an alarm escalation scheme 40 in effect to name but a few possible considerations.
The patient care system 10 described herein, in one or more of the embodiments disclosed, has advantages over current systems in increased patient safety and increased ease of use for the clinicians. With respect to increased patient safety, the patient care system 10 in one or more embodiments increases patient safety by sounding an alarm when the alarm forwarding does not reach clinical personnel or they are unable to respond to or acknowledge the alarm in a timely manner. In this way, the possibility of a clinician missing or failing to respond to an alarm is decreased. The possibility of a clinician missing or failing to respond to an alarm is also decreased, and thus patient safety is increased, by creating alarm escalation procedures that help medical personnel back up each other in case an initial alarm is missed or failed to be responded to. Further, patient safety increases with one or more embodiments of the patient care system 10 because reaction time by medical personnel to adverse infusion events or pending adverse infusion events is reduced. This reaction time is reduced by alerting medical personnel to such adverse event or pending adverse event even though the medical personnel is physically distant from the pump 12.
Additionally, patient safety is increased in one or more embodiments of the patient care system 10 by creating a system of alarm evaluation and dispatch that operates according to rules, algorithms or instructions so that alarm management logic is removed from the individual and various monitor/controller systems 18 and corresponding communication technology and is instead governed and controlled by a reduced set (in some cases, a single set) of rules, algorithms and instructions operating on a smaller number of devices (in some cases, on a single dispatching system 14).
Further, patient safety is increased in one or more embodiments of the patient care system 10 by allowing medical personnel to program or modify an infusion without exposing the patient to unnecessary contact or the requirement that the pump 12 be programmed at the pump 12 itself. Because the clinician does not need to be physically present or come in contact directly with the pump 12, the likelihood of contamination of the patient by the clinician is reduced. In addition, because the clinician does not need to be physically present or contact the pump 12 directly, the likelihood of cross contamination by multiple clinicians is reduced when multiple clinicians utilize the same infusion pump 12. In this way, the pump 12 is not contaminated by a clinician in the first place and even if the pump 12 were initially contaminated, cross-contamination is eliminated because subsequent clinicians do not need to come in contact with or be in close proximity to the pump 12 to change or modify programming on pump 12 or check the status of the pump 12 or an infusion program running on pump 12. If necessary confirmations or double checks of program values previously done at the pump 12 can be done by the clinician on the monitor/controlling system 18.
In yet other embodiments of the patient care system 10, patient safety increases by reducing the chance of incorrect therapy delivery. The chance of delivering an incorrect therapy is reduced because the clinician need only become familiar with a single interface (monitor/controlling system 18) instead of needing to gain familiarity with the interfaces on a large number of devices which might be involved in therapy delivery. Further, the chance of delivering an incorrect therapy is reduced in one or more embodiments because there are checks built into the rules, algorithms or instructions implemented on the patient care system 10.
The patient care system 10 also increases ease of use for the clinicians. With respect to increasing ease of use, in one or more embodiments of the patient care system 10, patient care system 10 allows medical personnel to clear alarms remotely instead of requiring the personnel to move to the pump 12 to clear the alarm. Further, in one or more embodiments of the patient case system 10, ease of use for medical personnel is increased by reducing the time necessary and the difficulty involved in modifying or updating programming and infusion program updates. Besides producing a simplified process for modifying or updating such programming, ease of use is increased by requiring the clinician to become familiar with only a single interface (e.g., monitor/controlling system 18) instead of the interfaces for each device that might be involved in therapy delivery.
In addition, the patient care system 10, in one or more embodiments, increases ease of use for medical personnel by sending alarm messages to medical personnel even 5 when they are not in proximity of the device (i.e., they are outside of visual and acoustic range of the pump 12). Further, in one or more embodiments, information that is useful or needed by the medical personnel about an alarm message such as the pump 12 ID, pump 12 location, patient information, drug information, program information, etc. are provided with the alarm message to aid such personnel in evaluating the alarm. As a result, medical personnel can have greater range from their patients and still deliver safe and effective therapy.
Another aspect of the patient care system 10 that increases ease of use for medical personnel in one or more embodiments of the patient care system 10 is that alarm noise in the hospital is reduced, which is beneficial—especially at night time. The reduction in alarm noise is due to the processing of alarms according to rules, algorithms or instructions to eliminate false or unnecessary alarms thereby producing fewer audible or visual alarms. Reducing the number of annoying distracting, false or unnecessary alarms benefits not only the medical personnel but the patient and other nearby patients as well.
Not all of these advantages will be present in every embodiment of the patient care system 10; some embodiments may have only one of these advantages while other embodiments will have more than one advantage and some embodiments may have all of the advantages. The disclosure has been directed to certain embodiments, combinations, configurations and relative dimensions. It is to be understood, however, that the description given herein has been given for the purpose of explaining and illustrating the invention and are not intended to limit the scope of the invention. It is to be further understood that changes and modifications to the descriptions given herein will occur to those skilled in the art. Therefore, the scope of the invention should be limited only by the scope of the claims.
This application is a continuation of U.S. patent application Ser. No. 16/846,882, entitled “Patient Care System with Conditional Alarm Forwarding,” filed Apr. 13, 2020, which is a continuation of U.S. patent application Ser. No. 16/408,272, entitled “Patient Care System with Conditional Alarm Forwarding,” filed May 9, 2019, which is a continuation of U.S. patent application Ser. No. 15/674,889, entitled “Patient Care System with Conditional Alarm Forwarding,” filed Aug. 11, 2017, which is a continuation of U.S. patent application Ser. No. 14/700,357, entitled “Patient Care System with Conditional Alarm Forwarding,” filed Apr. 30, 2015, which claims the benefit of priority to U.S. Provisional Patent Application No. 61/986,562, entitled “Patient Care System with Conditional Alarm Forwarding,” filed Apr. 30, 2014, the disclosures of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4024864 | Davies et al. | May 1977 | A |
4055175 | Clemens et al. | Oct 1977 | A |
4151845 | Clemens | May 1979 | A |
4213454 | Shim | Jul 1980 | A |
4240438 | Updike et al. | Dec 1980 | A |
4280494 | Cosgrove et al. | Jul 1981 | A |
4308866 | Jeliffe | Jan 1982 | A |
4370983 | Lichtenstein et al. | Feb 1983 | A |
4373527 | Fischell | Feb 1983 | A |
4392849 | Petre et al. | Jul 1983 | A |
4395259 | Prestele et al. | Jul 1983 | A |
4457751 | Rodler | Jul 1984 | A |
4464170 | Clemens | Aug 1984 | A |
4469481 | Kobayashi | Sep 1984 | A |
4475901 | Kraegen et al. | Oct 1984 | A |
4494950 | Fischell | Jan 1985 | A |
4498843 | Schneider et al. | Feb 1985 | A |
4515584 | Abe et al. | May 1985 | A |
4526568 | Clemens et al. | Jul 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4543955 | Schroeppel | Oct 1985 | A |
4551133 | Zegers de Beyl et al. | Nov 1985 | A |
4553958 | LeCocq | Nov 1985 | A |
4559037 | Franetzki et al. | Dec 1985 | A |
4613937 | Batty | Sep 1986 | A |
4624661 | Arimond | Nov 1986 | A |
4633878 | Bombardieri | Jan 1987 | A |
4634426 | kamen | Jan 1987 | A |
4634427 | Hannula et al. | Jan 1987 | A |
4674652 | Aten et al. | Jun 1987 | A |
4676776 | Howson et al. | Jun 1987 | A |
4679562 | Luksha | Jul 1987 | A |
4685903 | Cable et al. | Aug 1987 | A |
4695954 | Rose | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4714462 | DiDomenico | Dec 1987 | A |
4722734 | Kolin | Feb 1988 | A |
4730849 | Siegel | Mar 1988 | A |
4731051 | Fischell | Mar 1988 | A |
4741732 | Crankshaw et al. | May 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4776842 | Franetzki et al. | Oct 1988 | A |
4785969 | McLaughlin | Nov 1988 | A |
4803625 | Fu et al. | Feb 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4838275 | Lee | Jun 1989 | A |
4838856 | Mulreany et al. | Jun 1989 | A |
4838857 | Strowe et al. | Jun 1989 | A |
4854324 | Hirschman et al. | Aug 1989 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
4858154 | Anderson et al. | Aug 1989 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4908017 | Howson et al. | Mar 1990 | A |
4933873 | Kaufman et al. | Jun 1990 | A |
4943279 | Samiotes et al. | Jul 1990 | A |
4946439 | Eggers | Aug 1990 | A |
4953745 | Rowlett | Sep 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
5000739 | Kulisz et al. | Mar 1991 | A |
5010473 | Jacobs | Apr 1991 | A |
5014698 | Cohen | May 1991 | A |
5016172 | Dessertine | May 1991 | A |
5026084 | Paisfield | Jun 1991 | A |
5034004 | Crankshaw | Jul 1991 | A |
5041086 | Koenig et al. | Aug 1991 | A |
5058161 | Weiss | Oct 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5084828 | Kaufman et al. | Jan 1992 | A |
5088981 | Howson et al. | Feb 1992 | A |
5097505 | Weiss | Mar 1992 | A |
5100380 | Epstein et al. | Mar 1992 | A |
5102392 | Sakai et al. | Apr 1992 | A |
5104374 | Bishko et al. | Apr 1992 | A |
5109850 | Blanco et al. | May 1992 | A |
5131816 | Brown | Jul 1992 | A |
5142484 | Kaufman et al. | Aug 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5157640 | Backner | Oct 1992 | A |
5161222 | Montejo et al. | Nov 1992 | A |
5177993 | Beckman et al. | Jan 1993 | A |
5181910 | Scanlon | Jan 1993 | A |
5190522 | Wocicki et al. | Mar 1993 | A |
5199439 | Zimmerman et al. | Apr 1993 | A |
5200891 | Kehr et al. | Apr 1993 | A |
5216597 | Beckers | Jun 1993 | A |
5221268 | Barton et al. | Jun 1993 | A |
5230061 | Welch | Jul 1993 | A |
5243982 | Möstl et al. | Sep 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5249260 | Nigawara et al. | Sep 1993 | A |
5256156 | Kern et al. | Oct 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5261702 | Mayfield | Nov 1993 | A |
5317506 | Coutre et al. | May 1994 | A |
5319355 | Russek | Jun 1994 | A |
5319363 | Welch | Jun 1994 | A |
5330634 | Wong et al. | Jul 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5341476 | Lowell | Aug 1994 | A |
5364346 | Schrezenmeir | Nov 1994 | A |
5366346 | Danby | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5373454 | Kanda et al. | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5378231 | Johnson et al. | Jan 1995 | A |
5389071 | Kawahara et al. | Feb 1995 | A |
5389078 | Zalesky et al. | Feb 1995 | A |
5417222 | Dempsey et al. | May 1995 | A |
5423748 | Uhala | Jun 1995 | A |
5429602 | Hauser | Jul 1995 | A |
5431627 | Pastrone et al. | Jul 1995 | A |
5432777 | Le Boudec et al. | Jul 1995 | A |
5445621 | Poli et al. | Aug 1995 | A |
5447164 | Shaya et al. | Sep 1995 | A |
5455851 | Chaco et al. | Oct 1995 | A |
5461365 | Schlager et al. | Oct 1995 | A |
5464392 | Epstein et al. | Nov 1995 | A |
5465082 | Chaco | Nov 1995 | A |
5485408 | Blomquist | Jan 1996 | A |
5486286 | Peterson et al. | Jan 1996 | A |
5493430 | Lu et al. | Feb 1996 | A |
5496273 | Pastrone et al. | Mar 1996 | A |
5505828 | Wong et al. | Apr 1996 | A |
5507288 | Bocker et al. | Apr 1996 | A |
5507786 | Morgan et al. | Apr 1996 | A |
5508499 | Ferrario | Apr 1996 | A |
5515713 | Saugues et al. | May 1996 | A |
5520637 | Pager et al. | May 1996 | A |
5522798 | Johnson et al. | Jun 1996 | A |
5547470 | Johnson et al. | Aug 1996 | A |
5554013 | Owens et al. | Sep 1996 | A |
5562615 | Nassif | Oct 1996 | A |
5577169 | Prezioso | Nov 1996 | A |
5582323 | Kurtenbach | Dec 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5594786 | Chaco et al. | Jan 1997 | A |
5598519 | Narayanan | Jan 1997 | A |
5620608 | Rosa et al. | Apr 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5636044 | Yuan et al. | Jun 1997 | A |
5643212 | Coutre et al. | Jul 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5658131 | Aoki et al. | Aug 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5665065 | Colman et al. | Sep 1997 | A |
5669877 | Blomquist | Sep 1997 | A |
5672154 | Sillén et al. | Sep 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5687717 | Halpern et al. | Nov 1997 | A |
5689229 | Chaco et al. | Nov 1997 | A |
5697899 | Hillman et al. | Dec 1997 | A |
5699509 | Gary et al. | Dec 1997 | A |
5713350 | Yokota et al. | Feb 1998 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5718562 | Lawless et al. | Feb 1998 | A |
5719761 | Gatti et al. | Feb 1998 | A |
5733259 | Valcke et al. | Mar 1998 | A |
5738102 | Lemelson | Apr 1998 | A |
5744027 | Connell et al. | Apr 1998 | A |
5752621 | Passamante | May 1998 | A |
5754111 | Garcia | May 1998 | A |
5764034 | Bowman et al. | Jun 1998 | A |
5764159 | Neftel et al. | Jun 1998 | A |
5772635 | Dastur et al. | Jun 1998 | A |
5774865 | Glynn | Jun 1998 | A |
5778256 | Darbee | Jul 1998 | A |
5778345 | McCartney | Jul 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5788669 | Peterson | Aug 1998 | A |
5797515 | Liff et al. | Aug 1998 | A |
5800387 | Duffy et al. | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5827179 | Lichter et al. | Oct 1998 | A |
5832448 | Brown | Nov 1998 | A |
5836910 | Duffy et al. | Nov 1998 | A |
5850344 | Conkright | Dec 1998 | A |
5867821 | Ballantyne et al. | Feb 1999 | A |
5870733 | Bass et al. | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
5873731 | Predergast | Feb 1999 | A |
5885245 | Lynch et al. | Mar 1999 | A |
5897493 | Brown | Apr 1999 | A |
5897498 | Canfield, II et al. | Apr 1999 | A |
5910252 | Truitt et al. | Jun 1999 | A |
5912818 | McGrady et al. | Jun 1999 | A |
5915240 | Karpf | Jun 1999 | A |
5920054 | Uber, III | Jul 1999 | A |
5920263 | Huttenhoff et al. | Jul 1999 | A |
5924074 | Evans | Jul 1999 | A |
5931764 | Freeman et al. | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5941846 | Duffy et al. | Aug 1999 | A |
5956501 | Brown | Sep 1999 | A |
5957885 | Bollish et al. | Sep 1999 | A |
5960085 | de la Huerga | Sep 1999 | A |
5961448 | Swenson et al. | Oct 1999 | A |
5967559 | Abramowitz | Oct 1999 | A |
5971594 | Sahai et al. | Oct 1999 | A |
5975081 | Hood et al. | Nov 1999 | A |
5990838 | Burns et al. | Nov 1999 | A |
5997476 | Brown | Dec 1999 | A |
6000828 | Leet | Dec 1999 | A |
6003006 | Colella et al. | Dec 1999 | A |
6012034 | Hamparian et al. | Jan 2000 | A |
6017318 | Gauthier et al. | Jan 2000 | A |
6021392 | Lester et al. | Feb 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6032155 | de la Huerga | Feb 2000 | A |
6032676 | Moore | Mar 2000 | A |
6039251 | Holowko et al. | Mar 2000 | A |
6070761 | Bloom et al. | Jun 2000 | A |
6073106 | Rozen et al. | Jun 2000 | A |
6104295 | Gaisser et al. | Aug 2000 | A |
6112182 | Akers et al. | Aug 2000 | A |
6112323 | Meizlik et al. | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6115390 | Chuah | Sep 2000 | A |
6122536 | Sun et al. | Sep 2000 | A |
6126637 | Kriesel et al. | Oct 2000 | A |
6135949 | Russo et al. | Oct 2000 | A |
6150942 | O'Brien | Nov 2000 | A |
6151643 | Cheng et al. | Nov 2000 | A |
6157914 | Seto et al. | Dec 2000 | A |
6159147 | Lichter et al. | Dec 2000 | A |
6167567 | Chiles et al. | Dec 2000 | A |
6182667 | Hanks et al. | Feb 2001 | B1 |
6189105 | Lopes | Feb 2001 | B1 |
6195589 | Ketcham | Feb 2001 | B1 |
6208974 | Campbell et al. | Mar 2001 | B1 |
6222323 | Yamashita et al. | Apr 2001 | B1 |
6223440 | Rashman | May 2001 | B1 |
6226277 | Chuah | May 2001 | B1 |
6227371 | Song | May 2001 | B1 |
6234176 | Domae et al. | May 2001 | B1 |
6241704 | Peterson et al. | Jun 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6249705 | Snell | Jun 2001 | B1 |
6257265 | Brunner et al. | Jul 2001 | B1 |
6259355 | Chaco et al. | Jul 2001 | B1 |
6269340 | Ford et al. | Jul 2001 | B1 |
6270455 | Brown | Aug 2001 | B1 |
6271813 | Palalau | Aug 2001 | B1 |
6277072 | Bardy | Aug 2001 | B1 |
6280380 | Bardy | Aug 2001 | B1 |
6283761 | Joao | Sep 2001 | B1 |
6285665 | Chuah | Sep 2001 | B1 |
6292860 | Cochcroft, Jr. | Sep 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6327254 | Chuah | Dec 2001 | B1 |
6330008 | Razdow et al. | Dec 2001 | B1 |
6339718 | Zatezalo et al. | Jan 2002 | B1 |
6346886 | de la Huerga | Feb 2002 | B1 |
6363282 | Nichols et al. | Mar 2002 | B1 |
6371719 | Hildebrandt | Apr 2002 | B1 |
6377548 | Chuah | Apr 2002 | B1 |
6388951 | Matsumoto et al. | May 2002 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6408330 | de la Huerga | Jun 2002 | B1 |
6418334 | Unger et al. | Jul 2002 | B1 |
6427088 | Bowman et al. | Jul 2002 | B1 |
6428483 | Carlebach | Aug 2002 | B1 |
6442432 | Lee | Aug 2002 | B2 |
6469991 | Chuah | Oct 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6482158 | Mault | Nov 2002 | B2 |
6485418 | Yasushi et al. | Nov 2002 | B2 |
6494694 | Lawless et al. | Dec 2002 | B2 |
6494831 | Koritzinsky | Dec 2002 | B1 |
6497680 | Holst et al. | Dec 2002 | B1 |
6514460 | Fendrock | Feb 2003 | B1 |
6517482 | Eiden et al. | Feb 2003 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
6520930 | Critchlow et al. | Feb 2003 | B2 |
6540672 | Simonsen et al. | Apr 2003 | B1 |
6542902 | Dulong et al. | Apr 2003 | B2 |
6544212 | Galley et al. | Apr 2003 | B2 |
6544228 | Heitmeier | Apr 2003 | B1 |
6546350 | Hartmann et al. | Apr 2003 | B1 |
6551276 | Mann et al. | Apr 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6558320 | Causey et al. | May 2003 | B1 |
6558351 | Steil et al. | May 2003 | B1 |
6565509 | Say et al. | May 2003 | B1 |
6567416 | Chuah | May 2003 | B1 |
6571294 | Simmon et al. | May 2003 | B2 |
6572542 | Houben et al. | Jun 2003 | B1 |
6572545 | Knobbe et al. | Jun 2003 | B2 |
6578002 | Derzay et al. | Jun 2003 | B1 |
6581117 | Klein et al. | Jun 2003 | B1 |
6587034 | Heiman et al. | Jul 2003 | B1 |
6589229 | Connelly et al. | Jul 2003 | B1 |
6599281 | Struys et al. | Jul 2003 | B1 |
6602191 | Quy | Aug 2003 | B2 |
6605072 | Struys et al. | Aug 2003 | B2 |
6628809 | Rowe et al. | Sep 2003 | B1 |
6631353 | Davis et al. | Oct 2003 | B1 |
6640246 | Gardy, Jr. et al. | Oct 2003 | B1 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6647299 | Bourget | Nov 2003 | B2 |
6652455 | Kocher | Nov 2003 | B1 |
6653937 | Nelson et al. | Nov 2003 | B2 |
6659947 | Carter et al. | Dec 2003 | B1 |
6669630 | Joliat et al. | Dec 2003 | B1 |
6671563 | Engleson et al. | Dec 2003 | B1 |
6673033 | Sciulli et al. | Jan 2004 | B1 |
6674403 | Gray et al. | Jan 2004 | B2 |
6681003 | Linder et al. | Jan 2004 | B2 |
6689091 | Bui et al. | Feb 2004 | B2 |
6692241 | Watanabe et al. | Feb 2004 | B2 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6694334 | DuLong et al. | Feb 2004 | B2 |
6721286 | Williams et al. | Apr 2004 | B1 |
6721582 | Trepagnier et al. | Apr 2004 | B2 |
6725200 | Rost | Apr 2004 | B1 |
6731989 | Engleson et al. | May 2004 | B2 |
6740072 | Starkweather et al. | May 2004 | B2 |
6751651 | Crockett | Jun 2004 | B2 |
6752787 | Causey, III et al. | Jun 2004 | B1 |
6753830 | Gelbman | Jun 2004 | B2 |
6758810 | Lebel et al. | Jul 2004 | B2 |
6773396 | Flach et al. | Aug 2004 | B2 |
6774786 | Havekost et al. | Aug 2004 | B1 |
6775577 | Cmkovich et al. | Aug 2004 | B2 |
6780156 | Haueter et al. | Aug 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6796956 | Hartlaub et al. | Sep 2004 | B2 |
6799149 | Hartlaub | Sep 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6811534 | Bowman, IV et al. | Nov 2004 | B2 |
6816605 | Rowe et al. | Nov 2004 | B2 |
6839753 | Biondi et al. | Jan 2005 | B2 |
6852104 | Blomquist | Feb 2005 | B2 |
6859134 | Heiman et al. | Feb 2005 | B1 |
6871211 | Labounty et al. | Mar 2005 | B2 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6876303 | Reeder et al. | Apr 2005 | B2 |
6885881 | Leonhardt | Apr 2005 | B2 |
6891525 | Ogoro | May 2005 | B2 |
6892278 | Ebergen | May 2005 | B2 |
6899695 | Herrera | May 2005 | B2 |
6915170 | Engleson et al. | Jul 2005 | B2 |
6923763 | Kovatchev et al. | Aug 2005 | B1 |
6924781 | Gelbman | Aug 2005 | B1 |
6928338 | Buchser et al. | Aug 2005 | B1 |
6928490 | Bucholz et al. | Aug 2005 | B1 |
6936029 | Mann et al. | Aug 2005 | B2 |
6945954 | Hochman et al. | Sep 2005 | B2 |
6948492 | Wemeling et al. | Sep 2005 | B2 |
6958677 | Carter | Oct 2005 | B1 |
6958691 | Anderson et al. | Oct 2005 | B1 |
6958705 | Lebel et al. | Oct 2005 | B2 |
6961448 | Nichols et al. | Nov 2005 | B2 |
6969352 | Chiang et al. | Nov 2005 | B2 |
6969865 | Duchon et al. | Nov 2005 | B2 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6979326 | Mann et al. | Dec 2005 | B2 |
6980958 | Surwit et al. | Dec 2005 | B1 |
6985870 | Martucci et al. | Jan 2006 | B2 |
6986347 | Hickle | Jan 2006 | B2 |
6997880 | Carlebach et al. | Feb 2006 | B2 |
6997920 | Mann et al. | Feb 2006 | B2 |
6998984 | Zittrain | Feb 2006 | B1 |
7017293 | Riley | Mar 2006 | B2 |
7025743 | Mann et al. | Apr 2006 | B2 |
7029455 | Flaherty | Apr 2006 | B2 |
7038584 | Carter | May 2006 | B2 |
7060031 | Webb et al. | Jun 2006 | B2 |
7060059 | Keith et al. | Jun 2006 | B2 |
7069552 | Lindberg et al. | Jun 2006 | B2 |
7072725 | Bristol et al. | Jul 2006 | B2 |
7079035 | Bock et al. | Jul 2006 | B2 |
7092943 | Roese et al. | Aug 2006 | B2 |
7096072 | Engleson et al. | Aug 2006 | B2 |
7099809 | Dori | Aug 2006 | B2 |
7103419 | Engleson et al. | Sep 2006 | B2 |
7103578 | Beck et al. | Sep 2006 | B2 |
7107106 | Engleson et al. | Sep 2006 | B2 |
7108680 | Rohr et al. | Sep 2006 | B2 |
7109878 | Mann et al. | Sep 2006 | B2 |
7114002 | Okumura et al. | Sep 2006 | B1 |
7117041 | Engleson et al. | Oct 2006 | B2 |
7136645 | Hanson et al. | Nov 2006 | B2 |
7137964 | Flaherty | Nov 2006 | B2 |
7142190 | Martinez | Nov 2006 | B2 |
7150741 | Erickson et al. | Dec 2006 | B2 |
7153289 | Vasko | Dec 2006 | B2 |
7154397 | Zerhusen et al. | Dec 2006 | B2 |
7156807 | Carter et al. | Jan 2007 | B2 |
7158030 | Chung | Jan 2007 | B2 |
7161484 | Tsoukalis et al. | Jan 2007 | B2 |
7167755 | Seeberger et al. | Jan 2007 | B2 |
7167920 | Traversat | Jan 2007 | B2 |
7171277 | Engleson et al. | Jan 2007 | B2 |
7171492 | Borella et al. | Jan 2007 | B1 |
7181493 | English et al. | Feb 2007 | B2 |
7185288 | McKeever | Feb 2007 | B2 |
7193514 | Ritson | Mar 2007 | B2 |
7197025 | Chuah | Mar 2007 | B2 |
7201734 | Hickle | Apr 2007 | B2 |
7204823 | Estes et al. | Apr 2007 | B2 |
7213009 | Pestotnik | May 2007 | B2 |
7216802 | de la Huerga | May 2007 | B1 |
7220240 | Struys et al. | May 2007 | B2 |
7224979 | Singhal et al. | May 2007 | B2 |
7229430 | Hickle et al. | Jun 2007 | B2 |
7230529 | Ketcherside | Jun 2007 | B2 |
7236936 | White et al. | Jun 2007 | B2 |
7238164 | Childers et al. | Jul 2007 | B2 |
7247154 | Hickle | Jul 2007 | B2 |
7248239 | Dowling | Jul 2007 | B2 |
7250856 | Havekost et al. | Jul 2007 | B2 |
7255683 | Vanderveen et al. | Aug 2007 | B2 |
7256888 | Staehr et al. | Aug 2007 | B2 |
7258534 | Fathallah et al. | Aug 2007 | B2 |
7263213 | Rowe | Aug 2007 | B2 |
7267664 | Rizzo | Sep 2007 | B2 |
7267665 | Steil et al. | Sep 2007 | B2 |
7275156 | Balfanz et al. | Sep 2007 | B2 |
7278983 | Ireland et al. | Oct 2007 | B2 |
7289815 | Gfeller et al. | Oct 2007 | B2 |
7289948 | Mohri | Oct 2007 | B1 |
7293107 | Hanson et al. | Nov 2007 | B1 |
7295119 | Rappaport et al. | Nov 2007 | B2 |
7295556 | Roese et al. | Nov 2007 | B2 |
7301451 | Hastings | Nov 2007 | B2 |
7308300 | Toews et al. | Dec 2007 | B2 |
7315825 | Rosenfeld et al. | Jan 2008 | B2 |
7319386 | Collins, Jr. et al. | Jan 2008 | B2 |
7324000 | Zittrain et al. | Jan 2008 | B2 |
7327705 | Fletcher et al. | Feb 2008 | B2 |
7343224 | DiGianfilippo et al. | Mar 2008 | B2 |
7346025 | Bryson | Mar 2008 | B2 |
7347836 | Peterson et al. | Mar 2008 | B2 |
7354420 | Steil et al. | Apr 2008 | B2 |
7369897 | Boveja et al. | May 2008 | B2 |
7369948 | Ferenczi et al. | May 2008 | B1 |
7383088 | Spinelli et al. | Jun 2008 | B2 |
7384410 | Eggers et al. | Jun 2008 | B2 |
7398183 | Holland et al. | Jul 2008 | B2 |
7398279 | Muno, Jr. et al. | Jul 2008 | B2 |
7399277 | Saidara et al. | Jul 2008 | B2 |
7402153 | Steil et al. | Jul 2008 | B2 |
7420472 | Tran | Sep 2008 | B2 |
7432807 | Schmitt | Oct 2008 | B2 |
7447643 | Olson | Nov 2008 | B1 |
7454314 | Holland et al. | Nov 2008 | B2 |
7457804 | Uber, III et al. | Nov 2008 | B2 |
7464040 | Joao | Dec 2008 | B2 |
7471994 | Ford et al. | Dec 2008 | B2 |
7483756 | Engleson et al. | Jan 2009 | B2 |
7489808 | Gerder | Feb 2009 | B2 |
7490021 | Holland et al. | Feb 2009 | B2 |
7490048 | Joao | Feb 2009 | B2 |
7491187 | Van Den Berghe et al. | Feb 2009 | B2 |
7519905 | Kougiouris et al. | Apr 2009 | B2 |
7523401 | Aldridge | Apr 2009 | B1 |
7524304 | Genosar | Apr 2009 | B2 |
7551078 | Carlson | Jun 2009 | B2 |
7559321 | Wermeling et al. | Jul 2009 | B2 |
7565197 | Haulbrich et al. | Jul 2009 | B2 |
7572230 | Neumann et al. | Aug 2009 | B2 |
7578802 | Hickle | Aug 2009 | B2 |
7621009 | Elhabashy | Nov 2009 | B2 |
D606533 | De Jong et al. | Dec 2009 | S |
7636718 | Steen et al. | Dec 2009 | B1 |
7640172 | Kuth | Dec 2009 | B2 |
7645258 | White et al. | Jan 2010 | B2 |
7647237 | Malave et al. | Jan 2010 | B2 |
7662124 | Duchon et al. | Feb 2010 | B2 |
7668731 | Martucci et al. | Feb 2010 | B2 |
7671733 | McNeal et al. | Mar 2010 | B2 |
7678071 | Lebel et al. | Mar 2010 | B2 |
7687678 | Jacobs | Mar 2010 | B2 |
7697994 | VanDanacker et al. | Apr 2010 | B2 |
7698239 | Lieuallen | Apr 2010 | B2 |
7705727 | Pestotnik | Apr 2010 | B2 |
7724147 | Brown et al. | May 2010 | B2 |
7739126 | Cave | Jun 2010 | B1 |
7746218 | Collins, Jr. | Jun 2010 | B2 |
7766873 | Moberg et al. | Aug 2010 | B2 |
7776029 | Whitehurst et al. | Aug 2010 | B2 |
7776031 | Hartlaub et al. | Aug 2010 | B2 |
7785313 | Mastrototaro | Aug 2010 | B2 |
7788369 | McAllen et al. | Aug 2010 | B2 |
7806852 | Jurson | Oct 2010 | B1 |
7806886 | Kanderian, Jr. et al. | Oct 2010 | B2 |
7826981 | Goode, Jr. et al. | Nov 2010 | B2 |
7835927 | Schlotterbeck et al. | Nov 2010 | B2 |
7836314 | Chieu | Nov 2010 | B2 |
7856276 | Ripart et al. | Dec 2010 | B2 |
7860583 | Condurso et al. | Dec 2010 | B2 |
7864771 | Tavares et al. | Jan 2011 | B2 |
7868754 | Salvat, Jr. | Jan 2011 | B2 |
7871394 | Halbert et al. | Jan 2011 | B2 |
7886231 | Hopermann et al. | Feb 2011 | B2 |
7895053 | Holland et al. | Feb 2011 | B2 |
7896842 | Palmroos et al. | Mar 2011 | B2 |
7899546 | Sieracki et al. | Mar 2011 | B2 |
7905710 | Wang et al. | Mar 2011 | B2 |
7920061 | Klein et al. | Apr 2011 | B2 |
7933780 | de la Huerga | Apr 2011 | B2 |
7938796 | Moubayed | May 2011 | B2 |
7945452 | Fathallah et al. | May 2011 | B2 |
7974714 | Hoffberg | Jul 2011 | B2 |
7976508 | Hoag | Jul 2011 | B2 |
7996241 | Zak | Aug 2011 | B2 |
8034026 | Grant | Oct 2011 | B2 |
8038593 | Friedman et al. | Oct 2011 | B2 |
8048040 | Kiani | Nov 2011 | B2 |
8060576 | Chan et al. | Nov 2011 | B2 |
8065161 | Howard et al. | Nov 2011 | B2 |
8066672 | Mandro | Nov 2011 | B2 |
8075514 | Butterfield et al. | Dec 2011 | B2 |
8078983 | Davis et al. | Dec 2011 | B2 |
8082018 | Duchon et al. | Dec 2011 | B2 |
8082312 | Chan et al. | Dec 2011 | B2 |
8095692 | Mehta et al. | Jan 2012 | B2 |
8126730 | Dicks et al. | Feb 2012 | B2 |
8147448 | Sundar et al. | Apr 2012 | B2 |
8149131 | Blomquist | Apr 2012 | B2 |
8169914 | Bajpai | May 2012 | B2 |
8171094 | Chan et al. | May 2012 | B2 |
8172798 | Hungerford et al. | May 2012 | B2 |
8185322 | Schroeder et al. | May 2012 | B2 |
8195478 | Petersen et al. | Jun 2012 | B2 |
8206350 | Mann et al. | Jun 2012 | B2 |
8219413 | Martinez et al. | Jul 2012 | B2 |
8231578 | Fathallah et al. | Jul 2012 | B2 |
8234128 | Martucci et al. | Jul 2012 | B2 |
8267892 | Spencer et al. | Sep 2012 | B2 |
8271106 | Wehba et al. | Sep 2012 | B2 |
8287495 | Michaud et al. | Oct 2012 | B2 |
8291337 | Gannin et al. | Oct 2012 | B2 |
8298184 | DiPerna et al. | Oct 2012 | B2 |
8312272 | Serenyl et al. | Nov 2012 | B1 |
8352290 | Bartz et al. | Jan 2013 | B2 |
8359338 | Butterfield et al. | Jan 2013 | B2 |
8380536 | Howard et al. | Feb 2013 | B2 |
8387112 | Ranjan et al. | Feb 2013 | B1 |
8394077 | Jacobson et al. | Mar 2013 | B2 |
8398592 | Leibner-Druska | Mar 2013 | B2 |
8403908 | Jacobson et al. | Mar 2013 | B2 |
8435206 | Evans et al. | May 2013 | B2 |
8449523 | Brukalo et al. | May 2013 | B2 |
8452953 | Buck et al. | May 2013 | B2 |
8453645 | Figueiredo et al. | Jun 2013 | B2 |
8472630 | Konrad et al. | Jun 2013 | B2 |
8480648 | Burnett et al. | Jul 2013 | B2 |
8489427 | Simpson et al. | Jul 2013 | B2 |
8494879 | Davis et al. | Jul 2013 | B2 |
8504179 | Blomquist | Aug 2013 | B2 |
8517990 | Teel et al. | Aug 2013 | B2 |
8518021 | Stewart et al. | Aug 2013 | B2 |
8543416 | Palmroos et al. | Sep 2013 | B2 |
8551038 | Tsoukalis et al. | Oct 2013 | B2 |
8560345 | Wehba et al. | Oct 2013 | B2 |
8567681 | Borges et al. | Oct 2013 | B2 |
8577692 | Silkaitis et al. | Nov 2013 | B2 |
8579884 | Lanier et al. | Nov 2013 | B2 |
8626530 | Tran et al. | Jan 2014 | B1 |
8655676 | Wehba et al. | Feb 2014 | B2 |
8660860 | Wehba et al. | Feb 2014 | B2 |
8662388 | Belkin | Mar 2014 | B2 |
8666769 | Butler et al. | Mar 2014 | B2 |
8667293 | Birtwhistle et al. | Mar 2014 | B2 |
8687811 | Nierzwick et al. | Apr 2014 | B2 |
8700421 | Feng et al. | Apr 2014 | B2 |
8731960 | Butler et al. | May 2014 | B2 |
8768719 | Wehba et al. | Jul 2014 | B2 |
8771251 | Ruchti et al. | Jul 2014 | B2 |
8777894 | Butterfield et al. | Jul 2014 | B2 |
8777895 | Hsu et al. | Jul 2014 | B2 |
8799012 | Butler et al. | Aug 2014 | B2 |
8876793 | Ledford et al. | Nov 2014 | B2 |
8922330 | Moberg et al. | Dec 2014 | B2 |
8936565 | Chawla | Jan 2015 | B2 |
8945043 | Lee et al. | Feb 2015 | B2 |
8952794 | Blomquist et al. | Feb 2015 | B2 |
8959617 | Newlin et al. | Feb 2015 | B2 |
8998100 | Halbert et al. | Apr 2015 | B2 |
9026370 | Rubalcaba et al. | May 2015 | B2 |
9069887 | Gupta et al. | Jun 2015 | B2 |
9077544 | Baker et al. | Jul 2015 | B2 |
9089642 | Murphy et al. | Jul 2015 | B2 |
9114217 | Sur et al. | Aug 2015 | B2 |
9123077 | Silkaitis et al. | Sep 2015 | B2 |
9192712 | DeBelser et al. | Nov 2015 | B2 |
9240002 | Hume et al. | Jan 2016 | B2 |
9302035 | Marseille et al. | Apr 2016 | B2 |
9381296 | Arrizza et al. | Jul 2016 | B2 |
9393362 | Cozmi et al. | Jul 2016 | B2 |
9483615 | Roberts | Nov 2016 | B2 |
9498583 | Sur et al. | Nov 2016 | B2 |
9539383 | Kohlbrecher | Jan 2017 | B2 |
9572923 | Howard et al. | Feb 2017 | B2 |
9594875 | Arrizza et al. | Mar 2017 | B2 |
9604000 | Wehba et al. | Mar 2017 | B2 |
9641432 | Jha et al. | May 2017 | B2 |
9649431 | Gray et al. | May 2017 | B2 |
9662436 | Belkin et al. | May 2017 | B2 |
9690909 | Stewart et al. | Jun 2017 | B2 |
9707341 | Dumas, III et al. | Jul 2017 | B2 |
9717845 | Istoc | Aug 2017 | B2 |
9724470 | Day et al. | Aug 2017 | B2 |
9764082 | Day et al. | Sep 2017 | B2 |
9886550 | Lee et al. | Feb 2018 | B2 |
9943269 | Muhsin et al. | Apr 2018 | B2 |
9967739 | Proennecke et al. | May 2018 | B2 |
9971871 | Arrizza et al. | May 2018 | B2 |
9995611 | Ruchti et al. | Jun 2018 | B2 |
10022498 | Ruchti et al. | Jul 2018 | B2 |
10042986 | Ruchti et al. | Aug 2018 | B2 |
10046112 | Oruklu et al. | Aug 2018 | B2 |
10166328 | Oruklu et al. | Jan 2019 | B2 |
10173008 | Simpson et al. | Jan 2019 | B2 |
10238799 | Kohlbrecher | Mar 2019 | B2 |
10238801 | Wehba et al. | Mar 2019 | B2 |
10242060 | Butler et al. | Mar 2019 | B2 |
10300194 | Day et al. | May 2019 | B2 |
10311972 | Kohlbrecher et al. | Jun 2019 | B2 |
10314974 | Day et al. | Jun 2019 | B2 |
10333843 | Jha et al. | Jun 2019 | B2 |
10341866 | Spencer et al. | Jul 2019 | B1 |
10430761 | Hume et al. | Oct 2019 | B2 |
10434246 | Silkaitis et al. | Oct 2019 | B2 |
10453157 | Kamen et al. | Oct 2019 | B2 |
10463788 | Day | Nov 2019 | B2 |
10516536 | Rommel | Dec 2019 | B2 |
10617815 | Day et al. | Apr 2020 | B2 |
10646651 | Day et al. | May 2020 | B2 |
10692595 | Xavier et al. | Jun 2020 | B2 |
10740436 | Moskal et al. | Aug 2020 | B2 |
10741280 | Xavier et al. | Aug 2020 | B2 |
10757219 | Moskal | Aug 2020 | B2 |
10765799 | Belkin et al. | Sep 2020 | B2 |
10799632 | Kohlbrecher | Oct 2020 | B2 |
10812380 | Jha et al. | Oct 2020 | B2 |
10861592 | Xavier et al. | Dec 2020 | B2 |
10898641 | Day et al. | Jan 2021 | B2 |
10950339 | Xavier et al. | Mar 2021 | B2 |
10964428 | Xavier et al. | Mar 2021 | B2 |
11013861 | Wehba et al. | May 2021 | B2 |
11037668 | Ruchti et al. | Jun 2021 | B2 |
11052193 | Day et al. | Jul 2021 | B2 |
11139058 | Xavier et al. | Oct 2021 | B2 |
11152108 | Xavier et al. | Oct 2021 | B2 |
11152109 | Xavier et al. | Oct 2021 | B2 |
11152110 | Xavier et al. | Oct 2021 | B2 |
11194810 | Butler et al. | Dec 2021 | B2 |
11235100 | Howard et al. | Feb 2022 | B2 |
11289183 | Kohlbrecher | Mar 2022 | B2 |
11309070 | Xavier et al. | Apr 2022 | B2 |
20010016056 | Westphal et al. | Aug 2001 | A1 |
20010031944 | Peterson et al. | Oct 2001 | A1 |
20010032099 | Joao | Oct 2001 | A1 |
20010037060 | Thompson et al. | Nov 2001 | A1 |
20010044731 | Coffman et al. | Nov 2001 | A1 |
20010048027 | Walsh | Dec 2001 | A1 |
20010051787 | Haller et al. | Dec 2001 | A1 |
20010056358 | Dulong et al. | Dec 2001 | A1 |
20020010595 | Kapp | Jan 2002 | A1 |
20020013551 | Zaitsu et al. | Jan 2002 | A1 |
20020013723 | Mise | Jan 2002 | A1 |
20020015018 | Shimazu et al. | Feb 2002 | A1 |
20020019584 | Schulze et al. | Feb 2002 | A1 |
20020021700 | Hata et al. | Feb 2002 | A1 |
20020026103 | Norris et al. | Feb 2002 | A1 |
20020029776 | Blomquist | Mar 2002 | A1 |
20020032583 | Joao | Mar 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020040282 | Bailey et al. | Apr 2002 | A1 |
20020044043 | Chaco et al. | Apr 2002 | A1 |
20020082728 | Mueller et al. | Jun 2002 | A1 |
20020087115 | Hartlaub | Jul 2002 | A1 |
20020087116 | Hartlaub | Jul 2002 | A1 |
20020095486 | Bahl | Jul 2002 | A1 |
20020103675 | Vanelli | Aug 2002 | A1 |
20020123905 | Goodroe et al. | Sep 2002 | A1 |
20020143580 | Bristol et al. | Oct 2002 | A1 |
20020152239 | Bautista-Lloyd et al. | Oct 2002 | A1 |
20020154600 | Ido et al. | Oct 2002 | A1 |
20020173702 | Lebel et al. | Nov 2002 | A1 |
20020173875 | Wallace et al. | Nov 2002 | A1 |
20020194329 | Alling | Dec 2002 | A1 |
20030009244 | Engleson | Jan 2003 | A1 |
20030013959 | Grunwald et al. | Jan 2003 | A1 |
20030014222 | Klass et al. | Jan 2003 | A1 |
20030014817 | Gallant et al. | Jan 2003 | A1 |
20030025602 | Medema et al. | Feb 2003 | A1 |
20030028082 | Thompson | Feb 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030036744 | Struys et al. | Feb 2003 | A1 |
20030047126 | Tomaschko | Mar 2003 | A1 |
20030050621 | Lebel et al. | Mar 2003 | A1 |
20030059750 | Bindler et al. | Mar 2003 | A1 |
20030060688 | Ciarniello et al. | Mar 2003 | A1 |
20030069963 | Jayant et al. | Apr 2003 | A1 |
20030079746 | Hickle | May 2003 | A1 |
20030097529 | Arimilli et al. | May 2003 | A1 |
20030104982 | Wittmann et al. | Jun 2003 | A1 |
20030105389 | Noonan et al. | Jun 2003 | A1 |
20030106553 | Vanderveen | Jun 2003 | A1 |
20030115358 | Yun | Jun 2003 | A1 |
20030120384 | Haitin et al. | Jun 2003 | A1 |
20030125662 | Bui | Jul 2003 | A1 |
20030130616 | Steil | Jul 2003 | A1 |
20030135087 | Hickle et al. | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030140928 | Bui et al. | Jul 2003 | A1 |
20030140929 | Wilkes et al. | Jul 2003 | A1 |
20030141981 | Bui et al. | Jul 2003 | A1 |
20030143746 | Sage, Jr. | Jul 2003 | A1 |
20030144878 | Wilkes et al. | Jul 2003 | A1 |
20030158749 | Olchanski et al. | Aug 2003 | A1 |
20030187338 | Say et al. | Oct 2003 | A1 |
20030200116 | Forrester | Oct 2003 | A1 |
20030204416 | Acharya | Oct 2003 | A1 |
20030204781 | Peebles et al. | Oct 2003 | A1 |
20030212364 | Mann et al. | Nov 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030212821 | Gillies et al. | Nov 2003 | A1 |
20030217962 | Childers et al. | Nov 2003 | A1 |
20040008123 | Carrender et al. | Jan 2004 | A1 |
20040015132 | Brown | Jan 2004 | A1 |
20040019607 | Moubayed et al. | Jan 2004 | A1 |
20040030323 | Ullestad et al. | Feb 2004 | A1 |
20040039257 | Hickle | Feb 2004 | A1 |
20040057226 | Berthou et al. | Mar 2004 | A1 |
20040064341 | Langan et al. | Apr 2004 | A1 |
20040064342 | Browne et al. | Apr 2004 | A1 |
20040064435 | Moubayed et al. | Apr 2004 | A1 |
20040073811 | Sanin | Apr 2004 | A1 |
20040077934 | Massad | Apr 2004 | A1 |
20040078231 | Wilkes et al. | Apr 2004 | A1 |
20040078236 | Stoodley et al. | Apr 2004 | A1 |
20040085186 | Eveland et al. | May 2004 | A1 |
20040104271 | Martucci et al. | Jun 2004 | A1 |
20040122530 | Hansen | Jun 2004 | A1 |
20040128162 | Schlotterbeck et al. | Jul 2004 | A1 |
20040128163 | Goodman et al. | Jul 2004 | A1 |
20040133441 | Brady et al. | Jul 2004 | A1 |
20040139004 | Cohen et al. | Jul 2004 | A1 |
20040145480 | Despotis | Jul 2004 | A1 |
20040147034 | Gore et al. | Jul 2004 | A1 |
20040167464 | Ireland et al. | Aug 2004 | A1 |
20040167465 | Kohler | Aug 2004 | A1 |
20040167804 | Simpson | Aug 2004 | A1 |
20040172222 | Simpson et al. | Sep 2004 | A1 |
20040172283 | Vanderveen | Sep 2004 | A1 |
20040172301 | Mihai et al. | Sep 2004 | A1 |
20040172302 | Martucci et al. | Sep 2004 | A1 |
20040176667 | Mihai et al. | Sep 2004 | A1 |
20040176980 | Bulitta et al. | Sep 2004 | A1 |
20040176984 | White et al. | Sep 2004 | A1 |
20040181314 | Zaleski | Sep 2004 | A1 |
20040189708 | Larcheveque et al. | Sep 2004 | A1 |
20040193325 | Bonderud | Sep 2004 | A1 |
20040193328 | Butterfield et al. | Sep 2004 | A1 |
20040204673 | Flaherty et al. | Oct 2004 | A1 |
20040215278 | Stegink et al. | Oct 2004 | A1 |
20040220517 | Starkweather et al. | Nov 2004 | A1 |
20040225252 | Gillespie et al. | Nov 2004 | A1 |
20040236240 | Kraus et al. | Nov 2004 | A1 |
20040243438 | Mintz | Dec 2004 | A1 |
20040254434 | Goodnow et al. | Dec 2004 | A1 |
20050010269 | Lebel et al. | Jan 2005 | A1 |
20050020886 | Hutchinson et al. | Jan 2005 | A1 |
20050021006 | Tonnies | Jan 2005 | A1 |
20050027560 | Cook | Feb 2005 | A1 |
20050027567 | Taha | Feb 2005 | A1 |
20050038311 | Kuth | Feb 2005 | A1 |
20050038669 | Sachdeva et al. | Feb 2005 | A1 |
20050038680 | McMahon | Feb 2005 | A1 |
20050040226 | Al-Sheikh | Feb 2005 | A1 |
20050043620 | Fallows et al. | Feb 2005 | A1 |
20050049910 | Lancaster et al. | Mar 2005 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050055244 | Mullan et al. | Mar 2005 | A1 |
20050065465 | Lebel et al. | Mar 2005 | A1 |
20050065817 | Mihai et al. | Mar 2005 | A1 |
20050075544 | Shapiro et al. | Apr 2005 | A1 |
20050080801 | Kothandaraman et al. | Apr 2005 | A1 |
20050086071 | Fox, Jr. et al. | Apr 2005 | A1 |
20050086072 | Fox | Apr 2005 | A1 |
20050090808 | Malave et al. | Apr 2005 | A1 |
20050099624 | Staehr | May 2005 | A1 |
20050102162 | Blumenfeld | May 2005 | A1 |
20050102165 | Oshita et al. | May 2005 | A1 |
20050102167 | Kapoor | May 2005 | A1 |
20050102669 | Marney et al. | May 2005 | A1 |
20050107923 | Vanderveen | May 2005 | A1 |
20050108057 | Cohen et al. | May 2005 | A1 |
20050117529 | Ramos-Escano | Jun 2005 | A1 |
20050119788 | Engleson et al. | Jun 2005 | A1 |
20050119914 | Batch | Jun 2005 | A1 |
20050131739 | Rabinowitz et al. | Jun 2005 | A1 |
20050135306 | McAllen et al. | Jun 2005 | A1 |
20050137522 | Aoki | Jun 2005 | A1 |
20050137573 | McLaughlin | Jun 2005 | A1 |
20050138428 | McAllen et al. | Jun 2005 | A1 |
20050154769 | Eckart et al. | Jul 2005 | A1 |
20050160057 | Wefers et al. | Jul 2005 | A1 |
20050171503 | Van Den Berghe et al. | Aug 2005 | A1 |
20050171815 | Vanderveen | Aug 2005 | A1 |
20050177096 | Bollish et al. | Aug 2005 | A1 |
20050177395 | Blomquist | Aug 2005 | A1 |
20050182306 | Sloan | Aug 2005 | A1 |
20050182355 | Bui | Aug 2005 | A1 |
20050187950 | Parker | Aug 2005 | A1 |
20050192557 | Brauker et al. | Sep 2005 | A1 |
20050197554 | Polcha | Sep 2005 | A1 |
20050197621 | Poulsen et al. | Sep 2005 | A1 |
20050210037 | Wefers et al. | Sep 2005 | A1 |
20050216479 | Wefers et al. | Sep 2005 | A1 |
20050216480 | Wefers et al. | Sep 2005 | A1 |
20050223045 | Funahashi et al. | Oct 2005 | A1 |
20050224083 | Crass | Oct 2005 | A1 |
20050234746 | Funahashi | Oct 2005 | A1 |
20050240305 | Bogash et al. | Oct 2005 | A1 |
20050246416 | Blomquist | Nov 2005 | A1 |
20050251418 | Fox, Jr. et al. | Nov 2005 | A1 |
20050261660 | Choi | Nov 2005 | A1 |
20050273059 | Mernoe et al. | Dec 2005 | A1 |
20050273367 | Nourie et al. | Dec 2005 | A1 |
20050277873 | Stewart et al. | Dec 2005 | A1 |
20050277890 | Stewart et al. | Dec 2005 | A1 |
20050278194 | Holland et al. | Dec 2005 | A1 |
20060004772 | Hagan et al. | Jan 2006 | A1 |
20060009727 | O'Mahony et al. | Jan 2006 | A1 |
20060009734 | Martin | Jan 2006 | A1 |
20060010098 | Goodnow et al. | Jan 2006 | A1 |
20060042139 | Mendes | Mar 2006 | A1 |
20060047270 | Shelton | Mar 2006 | A1 |
20060053036 | Coffman et al. | Mar 2006 | A1 |
20060064020 | Burnes et al. | Mar 2006 | A1 |
20060074633 | Mahesh et al. | Apr 2006 | A1 |
20060074920 | Wefers et al. | Apr 2006 | A1 |
20060079831 | Gilbert | Apr 2006 | A1 |
20060089854 | Holland et al. | Apr 2006 | A1 |
20060089855 | Holland et al. | Apr 2006 | A1 |
20060100746 | Leibner-Druska | May 2006 | A1 |
20060100907 | Holland et al. | May 2006 | A1 |
20060106649 | Eggers et al. | May 2006 | A1 |
20060111943 | Wu | May 2006 | A1 |
20060116904 | Brem | Jun 2006 | A1 |
20060116907 | Rhodes et al. | Jun 2006 | A1 |
20060122481 | Sievenpiper et al. | Jun 2006 | A1 |
20060122867 | Eggers et al. | Jun 2006 | A1 |
20060129140 | Todd et al. | Jun 2006 | A1 |
20060129429 | Moubayed et al. | Jun 2006 | A1 |
20060129434 | Smitherman et al. | Jun 2006 | A1 |
20060129435 | Smitherman et al. | Jun 2006 | A1 |
20060136266 | Tarassenko et al. | Jun 2006 | A1 |
20060136271 | Eggers et al. | Jun 2006 | A1 |
20060143051 | Eggers et al. | Jun 2006 | A1 |
20060173260 | Gaoni et al. | Aug 2006 | A1 |
20060173406 | Hayes et al. | Aug 2006 | A1 |
20060173715 | Wang et al. | Aug 2006 | A1 |
20060173927 | Beyer et al. | Aug 2006 | A1 |
20060190302 | Eggers et al. | Aug 2006 | A1 |
20060195022 | Trepagnier et al. | Aug 2006 | A1 |
20060200007 | Brockway et al. | Sep 2006 | A1 |
20060200369 | Batch et al. | Sep 2006 | A1 |
20060211404 | Cromp et al. | Sep 2006 | A1 |
20060224141 | Rush et al. | Oct 2006 | A1 |
20060229918 | Fotsch et al. | Oct 2006 | A1 |
20060258985 | Russell | Nov 2006 | A1 |
20060259327 | Hoag | Nov 2006 | A1 |
20060264895 | Flanders | Nov 2006 | A1 |
20060267753 | Hussey et al. | Nov 2006 | A1 |
20060268710 | Appanna et al. | Nov 2006 | A1 |
20060270971 | Gelfand et al. | Nov 2006 | A1 |
20060277206 | Bailey et al. | Dec 2006 | A1 |
20060287885 | Frick | Dec 2006 | A1 |
20070015972 | Wang et al. | Jan 2007 | A1 |
20070016443 | Wachman et al. | Jan 2007 | A1 |
20070027506 | Stender et al. | Feb 2007 | A1 |
20070060796 | Kim | Mar 2007 | A1 |
20070060870 | Tolle et al. | Mar 2007 | A1 |
20070060871 | Istoc | Mar 2007 | A1 |
20070061393 | Moore | Mar 2007 | A1 |
20070065363 | Dalal et al. | Mar 2007 | A1 |
20070073419 | Sesay | Mar 2007 | A1 |
20070078314 | Grounsell | Apr 2007 | A1 |
20070083870 | Kanakogi | Apr 2007 | A1 |
20070088333 | Levin et al. | Apr 2007 | A1 |
20070093786 | Goldsmith et al. | Apr 2007 | A1 |
20070100665 | Brown | May 2007 | A1 |
20070100667 | Bardy | May 2007 | A1 |
20070106126 | Mannheimer et al. | May 2007 | A1 |
20070112298 | Mueller et al. | May 2007 | A1 |
20070116037 | Moore | May 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070135866 | Baker et al. | Jun 2007 | A1 |
20070136098 | Smythe et al. | Jun 2007 | A1 |
20070142822 | Remde | Jun 2007 | A1 |
20070156282 | Dunn | Jul 2007 | A1 |
20070156452 | Batch | Jul 2007 | A1 |
20070169008 | Varanasi et al. | Jul 2007 | A1 |
20070179448 | Lim et al. | Aug 2007 | A1 |
20070186923 | Poutiatine et al. | Aug 2007 | A1 |
20070191817 | Martin | Aug 2007 | A1 |
20070191973 | Holzbauer et al. | Aug 2007 | A1 |
20070213657 | Jennewine et al. | Sep 2007 | A1 |
20070213684 | Hickle et al. | Sep 2007 | A1 |
20070214003 | Holland et al. | Sep 2007 | A1 |
20070215545 | Bissler et al. | Sep 2007 | A1 |
20070229249 | McNeal | Oct 2007 | A1 |
20070232867 | Hansmann | Oct 2007 | A1 |
20070233035 | Wehba et al. | Oct 2007 | A1 |
20070233049 | Wehba et al. | Oct 2007 | A1 |
20070233206 | Frikart | Oct 2007 | A1 |
20070233520 | Wehba et al. | Oct 2007 | A1 |
20070251835 | Mehta et al. | Nov 2007 | A1 |
20070253021 | Mehta et al. | Nov 2007 | A1 |
20070254593 | Jollota et al. | Nov 2007 | A1 |
20070255125 | Moberg et al. | Nov 2007 | A1 |
20070257788 | Carlson | Nov 2007 | A1 |
20070258395 | Jollota et al. | Nov 2007 | A1 |
20070299687 | Palmer et al. | Dec 2007 | A1 |
20070299695 | Jung et al. | Dec 2007 | A1 |
20080004904 | Tran | Jan 2008 | A1 |
20080009684 | Corsetti et al. | Jan 2008 | A1 |
20080033361 | Evans et al. | Feb 2008 | A1 |
20080033966 | Wahl | Feb 2008 | A1 |
20080034323 | Blomquist | Feb 2008 | A1 |
20080041942 | Aissa | Feb 2008 | A1 |
20080052704 | Wysocki | Feb 2008 | A1 |
20080065007 | Peterson et al. | Mar 2008 | A1 |
20080065417 | Jung et al. | Mar 2008 | A1 |
20080071217 | Moubayed et al. | Mar 2008 | A1 |
20080071251 | Moubayed et al. | Mar 2008 | A1 |
20080091466 | Butler et al. | Apr 2008 | A1 |
20080095339 | Elliott | Apr 2008 | A1 |
20080097289 | Steil et al. | Apr 2008 | A1 |
20080126969 | Blomquist | May 2008 | A1 |
20080139907 | Rao et al. | Jun 2008 | A1 |
20080148047 | Appenzeller et al. | Jun 2008 | A1 |
20080149117 | Raghuram | Jun 2008 | A1 |
20080154177 | Moubayed | Jun 2008 | A1 |
20080172337 | Banfield et al. | Jul 2008 | A1 |
20080184219 | Matsumoto | Jul 2008 | A1 |
20080188796 | Steil et al. | Aug 2008 | A1 |
20080214919 | Harmon et al. | Sep 2008 | A1 |
20080246748 | Cassidy et al. | Oct 2008 | A1 |
20080256305 | Kwon | Oct 2008 | A1 |
20080259926 | Tavares et al. | Oct 2008 | A1 |
20080262469 | Bristol et al. | Oct 2008 | A1 |
20080269714 | Mastrototaro et al. | Oct 2008 | A1 |
20080269723 | Mastrototaro et al. | Oct 2008 | A1 |
20080275384 | Mastrototaro et al. | Nov 2008 | A1 |
20080300572 | Rankers | Dec 2008 | A1 |
20080301298 | Bernardi et al. | Dec 2008 | A1 |
20080320387 | Sasaki et al. | Dec 2008 | A1 |
20080320466 | Dias | Dec 2008 | A1 |
20090003554 | Katis et al. | Jan 2009 | A1 |
20090005703 | Fasciano | Jan 2009 | A1 |
20090005728 | Weinert et al. | Jan 2009 | A1 |
20090006061 | Thukral et al. | Jan 2009 | A1 |
20090006129 | Thukral | Jan 2009 | A1 |
20090006133 | Weinert | Jan 2009 | A1 |
20090018495 | Panduro | Jan 2009 | A1 |
20090051560 | Manning et al. | Feb 2009 | A1 |
20090054743 | Stewart | Feb 2009 | A1 |
20090054754 | McMahon et al. | Feb 2009 | A1 |
20090057399 | Sajkowsky | Mar 2009 | A1 |
20090063187 | Johnson et al. | Mar 2009 | A1 |
20090069785 | Miller et al. | Mar 2009 | A1 |
20090099867 | Newman | Apr 2009 | A1 |
20090135196 | Holland et al. | May 2009 | A1 |
20090143662 | Estes et al. | Jun 2009 | A1 |
20090149743 | Barron et al. | Jun 2009 | A1 |
20090150174 | Buck et al. | Jun 2009 | A1 |
20090150439 | Gejdos et al. | Jun 2009 | A1 |
20090150878 | Pathak et al. | Jun 2009 | A1 |
20090156991 | Roberts | Jun 2009 | A1 |
20090157695 | Roberts | Jun 2009 | A1 |
20090158274 | Roberts | Jun 2009 | A1 |
20090177146 | Nesbitt et al. | Jul 2009 | A1 |
20090177769 | Roberts | Jul 2009 | A1 |
20090177992 | Rubalcaba et al. | Jul 2009 | A1 |
20090183147 | Davis et al. | Jul 2009 | A1 |
20090209938 | Aalto-Setala | Aug 2009 | A1 |
20090210250 | Prax et al. | Aug 2009 | A1 |
20090221890 | Saffer et al. | Sep 2009 | A1 |
20090231249 | Wang et al. | Sep 2009 | A1 |
20090270833 | DeBelser | Oct 2009 | A1 |
20090275886 | Blomquist et al. | Nov 2009 | A1 |
20090275896 | Kamen et al. | Nov 2009 | A1 |
20090284691 | Marhefka et al. | Nov 2009 | A1 |
20090292340 | Mass et al. | Nov 2009 | A1 |
20090306573 | Gagner et al. | Dec 2009 | A1 |
20090326340 | Wang | Dec 2009 | A1 |
20090326516 | Bangera et al. | Dec 2009 | A1 |
20100022988 | Wochner | Jan 2010 | A1 |
20100036310 | Hillman | Feb 2010 | A1 |
20100056992 | Hayter | Mar 2010 | A1 |
20100083060 | Rahman | Apr 2010 | A1 |
20100095229 | Dixon et al. | Apr 2010 | A1 |
20100121170 | Rule | May 2010 | A1 |
20100121246 | Peters et al. | May 2010 | A1 |
20100121415 | Skelton et al. | May 2010 | A1 |
20100121654 | Portnoy et al. | May 2010 | A1 |
20100121752 | Banigan et al. | May 2010 | A1 |
20100130933 | Holland et al. | May 2010 | A1 |
20100131434 | Magent et al. | May 2010 | A1 |
20100138523 | Umess et al. | Jun 2010 | A1 |
20100146137 | Wu et al. | Jun 2010 | A1 |
20100156633 | Buck et al. | Jun 2010 | A1 |
20100160854 | Gauthier | Jun 2010 | A1 |
20100160860 | Celentano et al. | Jun 2010 | A1 |
20100174266 | Estes | Jul 2010 | A1 |
20100191525 | Rabenko et al. | Jul 2010 | A1 |
20100198034 | Thomas et al. | Aug 2010 | A1 |
20100198196 | Wei | Aug 2010 | A1 |
20100200506 | Ware et al. | Aug 2010 | A1 |
20100209268 | Davis | Aug 2010 | A1 |
20100212675 | Walling et al. | Aug 2010 | A1 |
20100217621 | Schoenberg | Aug 2010 | A1 |
20100234708 | Buck et al. | Sep 2010 | A1 |
20100250732 | Bucknell | Sep 2010 | A1 |
20100271479 | Heydlauf | Oct 2010 | A1 |
20100273738 | Valcke et al. | Oct 2010 | A1 |
20100274218 | Yodfat et al. | Oct 2010 | A1 |
20100280486 | Khair et al. | Nov 2010 | A1 |
20100292634 | Kircher | Nov 2010 | A1 |
20100298765 | Budiman et al. | Nov 2010 | A1 |
20100318025 | John | Dec 2010 | A1 |
20110001605 | Kiani et al. | Jan 2011 | A1 |
20110021898 | Wei et al. | Jan 2011 | A1 |
20110040158 | Katz et al. | Feb 2011 | A1 |
20110060758 | Schlotterbeck et al. | Mar 2011 | A1 |
20110071844 | Cannon et al. | Mar 2011 | A1 |
20110072379 | Gannon | Mar 2011 | A1 |
20110078253 | Chan et al. | Mar 2011 | A1 |
20110078608 | Gannon et al. | Mar 2011 | A1 |
20110093284 | Dicks et al. | Apr 2011 | A1 |
20110099313 | Bolanowski | Apr 2011 | A1 |
20110125095 | Lebel et al. | May 2011 | A1 |
20110138185 | Ju et al. | Jun 2011 | A1 |
20110175728 | Baker, Jr. | Jul 2011 | A1 |
20110178462 | Moberg et al. | Jul 2011 | A1 |
20110196748 | Caron et al. | Aug 2011 | A1 |
20110231216 | Fyke et al. | Sep 2011 | A1 |
20110257496 | Terashima et al. | Oct 2011 | A1 |
20110257798 | Ali et al. | Oct 2011 | A1 |
20110259954 | Bartz et al. | Oct 2011 | A1 |
20110264043 | Kotnick et al. | Oct 2011 | A1 |
20110264044 | Bartz et al. | Oct 2011 | A1 |
20110266221 | Ware et al. | Nov 2011 | A1 |
20110270045 | Lebel et al. | Nov 2011 | A1 |
20110275904 | Lebel et al. | Nov 2011 | A1 |
20110286457 | Ee | Nov 2011 | A1 |
20110289497 | Kiaie et al. | Nov 2011 | A1 |
20110295196 | Chazot et al. | Dec 2011 | A1 |
20110295341 | Estes et al. | Dec 2011 | A1 |
20110296051 | Vange | Dec 2011 | A1 |
20110296411 | Tang et al. | Dec 2011 | A1 |
20110313789 | Karmen et al. | Dec 2011 | A1 |
20110319813 | Kamen et al. | Dec 2011 | A1 |
20110320049 | Chossat et al. | Dec 2011 | A1 |
20120005680 | Dolby et al. | Jan 2012 | A1 |
20120011253 | Friedman et al. | Jan 2012 | A1 |
20120016305 | Jollota | Jan 2012 | A1 |
20120029941 | Malave et al. | Feb 2012 | A1 |
20120036102 | Fletcher et al. | Feb 2012 | A1 |
20120066501 | Xiong | Mar 2012 | A1 |
20120070045 | Vesper et al. | Mar 2012 | A1 |
20120095437 | Hemmerling | Apr 2012 | A1 |
20120112903 | Kaib et al. | May 2012 | A1 |
20120130198 | Beaule | May 2012 | A1 |
20120143116 | Ware et al. | Jun 2012 | A1 |
20120150556 | Galasso et al. | Jun 2012 | A1 |
20120157920 | Flachbart et al. | Jun 2012 | A1 |
20120179135 | Rinehart et al. | Jul 2012 | A1 |
20120179136 | Rinehart et al. | Jul 2012 | A1 |
20120185267 | Kamen et al. | Jul 2012 | A1 |
20120203177 | Lanier | Aug 2012 | A1 |
20120245554 | Kawamura | Sep 2012 | A1 |
20120259978 | Petersen et al. | Oct 2012 | A1 |
20120260012 | Gao-Saari et al. | Oct 2012 | A1 |
20120277716 | Ali et al. | Nov 2012 | A1 |
20120283630 | Lee et al. | Nov 2012 | A1 |
20120284734 | McQuaid et al. | Nov 2012 | A1 |
20120323212 | Murphy | Dec 2012 | A1 |
20130006666 | Schneider | Jan 2013 | A1 |
20130006702 | Wu | Jan 2013 | A1 |
20130012877 | Debelser et al. | Jan 2013 | A1 |
20130012879 | Debelser et al. | Jan 2013 | A1 |
20130012880 | Blomquist | Jan 2013 | A1 |
20130015980 | Evans et al. | Jan 2013 | A1 |
20130036403 | Geist | Feb 2013 | A1 |
20130036412 | Birtwhistle et al. | Feb 2013 | A1 |
20130066265 | Grant | Mar 2013 | A1 |
20130072872 | Yodfat et al. | Mar 2013 | A1 |
20130096444 | Condurso et al. | Apr 2013 | A1 |
20130096648 | Benson | Apr 2013 | A1 |
20130102963 | Marsh et al. | Apr 2013 | A1 |
20130138452 | Cork et al. | May 2013 | A1 |
20130144206 | Lee et al. | Jun 2013 | A1 |
20130150824 | Estes et al. | Jun 2013 | A1 |
20130167245 | Birtwhistle et al. | Jun 2013 | A1 |
20130173473 | Birtwhistle et al. | Jul 2013 | A1 |
20130191770 | Bartz et al. | Jul 2013 | A1 |
20130204188 | Kamen et al. | Aug 2013 | A1 |
20130218080 | Peterfreund et al. | Aug 2013 | A1 |
20130274669 | Stempfle et al. | Oct 2013 | A1 |
20130275539 | Gross | Oct 2013 | A1 |
20130291116 | Homer | Oct 2013 | A1 |
20130296823 | Melker et al. | Nov 2013 | A1 |
20130296984 | Burnett et al. | Nov 2013 | A1 |
20130317753 | Kamen et al. | Nov 2013 | A1 |
20130346108 | Kamen et al. | Dec 2013 | A1 |
20140025392 | Chandrasenan | Jan 2014 | A1 |
20140142963 | Hill et al. | May 2014 | A1 |
20140163517 | Finan et al. | Jun 2014 | A1 |
20140180711 | Kamen et al. | Jun 2014 | A1 |
20140194817 | Lee et al. | Jul 2014 | A1 |
20140197950 | Shupp et al. | Jul 2014 | A1 |
20140257251 | Bush et al. | Sep 2014 | A1 |
20140266790 | Al-Ali et al. | Sep 2014 | A1 |
20140266794 | Brown et al. | Sep 2014 | A1 |
20140269643 | Sun | Sep 2014 | A1 |
20140276571 | Ludolph | Sep 2014 | A1 |
20140280522 | Watte | Sep 2014 | A1 |
20140288947 | Simpson et al. | Sep 2014 | A1 |
20140294177 | Shastry et al. | Oct 2014 | A1 |
20140297329 | Rock | Oct 2014 | A1 |
20140316819 | Dunsirn et al. | Oct 2014 | A1 |
20140366878 | Baron | Dec 2014 | A1 |
20150005935 | Bae et al. | Jan 2015 | A1 |
20150006907 | Brouwer et al. | Jan 2015 | A1 |
20150066531 | Jacobson et al. | Mar 2015 | A1 |
20150100038 | McCann et al. | Apr 2015 | A1 |
20150100787 | Westin et al. | Apr 2015 | A1 |
20150117234 | Raman et al. | Apr 2015 | A1 |
20150151051 | Tsoukalis | Jun 2015 | A1 |
20150161354 | Blomquist | Jun 2015 | A1 |
20150199192 | Borges et al. | Jul 2015 | A1 |
20150230760 | Schneider | Aug 2015 | A1 |
20150328396 | Adams et al. | Nov 2015 | A1 |
20150371004 | Jones | Dec 2015 | A1 |
20150379237 | Mills et al. | Dec 2015 | A1 |
20160006695 | Prodoehl et al. | Jan 2016 | A1 |
20160015885 | Pananen et al. | Jan 2016 | A1 |
20160034655 | Gray et al. | Feb 2016 | A1 |
20160045661 | Gray et al. | Feb 2016 | A1 |
20160051749 | Istoc | Feb 2016 | A1 |
20160228633 | Welsch et al. | Aug 2016 | A1 |
20160241391 | Fenster | Aug 2016 | A1 |
20160285876 | Perez et al. | Sep 2016 | A1 |
20160317742 | Gannon et al. | Nov 2016 | A1 |
20160350513 | Jacobson et al. | Dec 2016 | A1 |
20170104645 | Wooton et al. | Apr 2017 | A1 |
20170147761 | Moskal et al. | May 2017 | A1 |
20170149567 | Moskal | May 2017 | A1 |
20170262590 | Karakosta et al. | Sep 2017 | A1 |
20170274140 | Howard et al. | Sep 2017 | A1 |
20170286637 | Arrizza et al. | Oct 2017 | A1 |
20170319780 | Belkin et al. | Nov 2017 | A1 |
20170325091 | Freeman et al. | Nov 2017 | A1 |
20170351841 | Moskal | Dec 2017 | A1 |
20180121613 | Connely, IV et al. | May 2018 | A1 |
20180126067 | Ledford et al. | May 2018 | A1 |
20180181712 | Ensey et al. | Jun 2018 | A1 |
20180247712 | Muhsin et al. | Aug 2018 | A1 |
20180322948 | Drost et al. | Nov 2018 | A1 |
20180359085 | Dervyn | Dec 2018 | A1 |
20190006044 | Brask | Jan 2019 | A1 |
20190096518 | Pace | Mar 2019 | A1 |
20190132196 | Trivedi et al. | May 2019 | A1 |
20190147998 | Ruchti et al. | May 2019 | A1 |
20190228863 | Dharwad et al. | Jul 2019 | A1 |
20190229982 | Ikuta et al. | Jul 2019 | A1 |
20190240405 | Wehba et al. | Aug 2019 | A1 |
20190243829 | Butler et al. | Aug 2019 | A1 |
20190244689 | Atkin | Aug 2019 | A1 |
20190245942 | Moskal | Aug 2019 | A1 |
20190269852 | Kohlbrecher | Sep 2019 | A1 |
20190311803 | Kohlbrecher et al. | Oct 2019 | A1 |
20190348160 | Heavelyn et al. | Nov 2019 | A1 |
20190392929 | Gassman | Dec 2019 | A1 |
20200023127 | Simpson et al. | Jan 2020 | A1 |
20200027541 | Xavier et al. | Jan 2020 | A1 |
20200027542 | Xavier et al. | Jan 2020 | A1 |
20200027543 | Xavier et al. | Jan 2020 | A1 |
20200027548 | Xavier et al. | Jan 2020 | A1 |
20200027549 | Xavier et al. | Jan 2020 | A1 |
20200027550 | Xavier et al. | Jan 2020 | A1 |
20200027551 | Xavier et al. | Jan 2020 | A1 |
20200028837 | Xavier et al. | Jan 2020 | A1 |
20200028914 | Xavier et al. | Jan 2020 | A1 |
20200028929 | Xavier et al. | Jan 2020 | A1 |
20200035355 | Xavier et al. | Jan 2020 | A1 |
20200054825 | Kamen et al. | Feb 2020 | A1 |
20200061291 | Day et al. | Feb 2020 | A1 |
20200145332 | Jha et al. | May 2020 | A1 |
20200206413 | Silkaitis et al. | Jul 2020 | A1 |
20200282139 | Susi | Sep 2020 | A1 |
20200330685 | Day | Oct 2020 | A1 |
20200335194 | Jacobson et al. | Oct 2020 | A1 |
20200351376 | Moskal | Nov 2020 | A1 |
20200353167 | Vivek et al. | Nov 2020 | A1 |
20200353168 | Keenan et al. | Nov 2020 | A1 |
20210043296 | Xavier et al. | Feb 2021 | A1 |
20210045640 | Poltorak | Feb 2021 | A1 |
20210050097 | Xavier et al. | Feb 2021 | A1 |
20210085855 | Belkin et al. | Mar 2021 | A1 |
20210098106 | Kohlbrecher et al. | Apr 2021 | A1 |
20210098107 | Xavier et al. | Apr 2021 | A1 |
20210105206 | Jha et al. | Apr 2021 | A1 |
20210358603 | Xavier et al. | Nov 2021 | A1 |
20210375421 | Ruchti et al. | Dec 2021 | A1 |
20210375438 | Xavier et al. | Dec 2021 | A1 |
20220023535 | Day | Jan 2022 | A1 |
20220037011 | Fryman | Feb 2022 | A1 |
20220037012 | Fryman | Feb 2022 | A1 |
20220051777 | Xavier et al. | Feb 2022 | A1 |
20220062541 | Kamen et al. | Mar 2022 | A1 |
20220139536 | Xavier et al. | May 2022 | A1 |
20220139537 | Xavier et al. | May 2022 | A1 |
20220139538 | Xavier et al. | May 2022 | A1 |
20220165404 | Vivek et al. | May 2022 | A1 |
Number | Date | Country |
---|---|---|
2 060 151 | Aug 1997 | CA |
2 125 300 | Oct 1999 | CA |
2 898 825 | Jul 2014 | CA |
31 12 762 | Jan 1983 | DE |
34 35 647 | Jul 1985 | DE |
198 44 252 | Mar 2000 | DE |
199 32 147 | Jan 2001 | DE |
103 52 456 | Jul 2005 | DE |
0 319 267 | Jun 1989 | EP |
0 380 061 | Aug 1990 | EP |
0 384 155 | Aug 1990 | EP |
0 460 533 | Dec 1991 | EP |
0 564 127 | Jun 1993 | EP |
0 633 035 | Jan 1995 | EP |
0 652 528 | May 1995 | EP |
0 672 427 | Sep 1995 | EP |
0 683 465 | Nov 1995 | EP |
0 880 936 | Dec 1998 | EP |
1 157 711 | Nov 2001 | EP |
1 174 817 | Jan 2002 | EP |
0 664 102 | Apr 2002 | EP |
1 197 178 | Apr 2002 | EP |
0 830 775 | Aug 2002 | EP |
1 500 025 | Apr 2003 | EP |
2 113 842 | Nov 2009 | EP |
2 228 004 | Sep 2010 | EP |
2 243 506 | Oct 2010 | EP |
2 410 448 | Jan 2012 | EP |
2 742 961 | Jun 2014 | EP |
2 717 919 | Sep 1995 | FR |
2 285 135 | Jun 1995 | GB |
04-161139 | Jun 1992 | JP |
07-502678 | Mar 1995 | JP |
11-500643 | Jan 1999 | JP |
2000-316820 | Nov 2000 | JP |
2002-531154 | Sep 2002 | JP |
2003-016183 | Jan 2003 | JP |
2003-296173 | Oct 2003 | JP |
2005-021463 | Jan 2005 | JP |
2005-527284 | Sep 2005 | JP |
2005-284846 | Oct 2005 | JP |
2006-047319 | Feb 2006 | JP |
2006-520949 | Sep 2006 | JP |
2007-518479 | Jul 2007 | JP |
2007-525256 | Sep 2007 | JP |
2008-080036 | Apr 2008 | JP |
2008-516303 | May 2008 | JP |
2008-158622 | Jul 2008 | JP |
2008-529675 | Aug 2008 | JP |
2009-163534 | Jul 2009 | JP |
2010-502361 | Jan 2010 | JP |
2011-506048 | Mar 2011 | JP |
2012-011204 | Jan 2012 | JP |
2012-070991 | Apr 2012 | JP |
2012-523895 | Oct 2012 | JP |
2014-068283 | Apr 2014 | JP |
WO 84001719 | May 1984 | WO |
WO 91016416 | Oct 1991 | WO |
WO 92010985 | Jul 1992 | WO |
WO 92013322 | Aug 1992 | WO |
WO 94005355 | Mar 1994 | WO |
WO 96008755 | Mar 1996 | WO |
WO 96025186 | Aug 1996 | WO |
WO 96025963 | Aug 1996 | WO |
WO 98012670 | Mar 1998 | WO |
WO 98019263 | May 1998 | WO |
WO 99051003 | Oct 1999 | WO |
WO 00013580 | Mar 2000 | WO |
WO 00053243 | Sep 2000 | WO |
WO 01014974 | Mar 2001 | WO |
WO 01033484 | May 2001 | WO |
WO 01045014 | Jun 2001 | WO |
WO 02005702 | Jan 2002 | WO |
WO 02036044 | May 2002 | WO |
WO 02049153 | Jun 2002 | WO |
WO 02049279 | Jun 2002 | WO |
WO 02069099 | Sep 2002 | WO |
WO 02081015 | Oct 2002 | WO |
WO 02088875 | Nov 2002 | WO |
WO 03006091 | Jan 2003 | WO |
WO 03050917 | Jun 2003 | WO |
WO 03091836 | Nov 2003 | WO |
WO 03094092 | Nov 2003 | WO |
WO 2004060455 | Jul 2004 | WO |
WO 2004070557 | Aug 2004 | WO |
WO 2004070562 | Aug 2004 | WO |
WO 2004072828 | Aug 2004 | WO |
WO 2005036447 | Apr 2005 | WO |
WO 2005050526 | Jun 2005 | WO |
WO 2005057175 | Jun 2005 | WO |
WO 2005066872 | Jul 2005 | WO |
WO 2007087443 | Aug 2007 | WO |
WO 2007117705 | Oct 2007 | WO |
WO 2007127879 | Nov 2007 | WO |
WO 2007127880 | Nov 2007 | WO |
WO 2008067245 | Jun 2008 | WO |
WO 2008082854 | Jul 2008 | WO |
WO 2008088490 | Jul 2008 | WO |
WO 2008097316 | Aug 2008 | WO |
WO 2008103915 | Aug 2008 | WO |
WO 2008124478 | Oct 2008 | WO |
WO 2008134146 | Nov 2008 | WO |
WO 2009016504 | Feb 2009 | WO |
WO 2009023406 | Feb 2009 | WO |
WO 2009023407 | Feb 2009 | WO |
WO 2009023634 | Feb 2009 | WO |
WO 2009036327 | Mar 2009 | WO |
WO 2009049252 | Apr 2009 | WO |
WO 2010017279 | Feb 2010 | WO |
WO 2010033919 | Mar 2010 | WO |
WO 2010053703 | May 2010 | WO |
WO 2010075371 | Jul 2010 | WO |
WO 2010099313 | Sep 2010 | WO |
WO 2010114929 | Oct 2010 | WO |
WO 2010119409 | Oct 2010 | WO |
WO 2010124127 | Oct 2010 | WO |
WO 2010130992 | Nov 2010 | WO |
WO 2010135646 | Nov 2010 | WO |
WO 2010135654 | Nov 2010 | WO |
WO 2010135686 | Nov 2010 | WO |
WO 2011005633 | Jan 2011 | WO |
WO 2011022549 | Feb 2011 | WO |
WO 2012048833 | Apr 2012 | WO |
WO 2012049214 | Apr 2012 | WO |
WO 2012049218 | Apr 2012 | WO |
WO 2012120078 | Sep 2012 | WO |
WO 2012140547 | Oct 2012 | WO |
WO 2012164556 | Dec 2012 | WO |
WO 2012170942 | Dec 2012 | WO |
WO 2013045506 | Apr 2013 | WO |
WO 2014100736 | Jun 2014 | WO |
WO 2014131729 | Sep 2014 | WO |
WO 2014131730 | Sep 2014 | WO |
WO 2015124569 | Aug 2015 | WO |
WO 2016179389 | Nov 2016 | WO |
WO 2019219290 | Nov 2019 | WO |
WO 2020227403 | Nov 2020 | WO |
WO 2022006014 | Jan 2022 | WO |
Entry |
---|
“Download”, Free On-Line Dictionary of Computing, as archived Jun. 16, 2010 in 1 page, http://web.archive.org/web/20100616010314/https://foldoc.org/download. |
Edworthy, Judy, “Medical Audible Alarms: A Review”, Journal of the American Medical Informatics Association, vol. 20, No. 3, 2013, pp. 584-589. |
“File Verification”, Wikipedia.org, as last modified Oct. 11, 2011 in 2 pages, https://en.wikipedia.org/w/index.php?title=File_verification&oldid=455048290. |
Gabel et al., “Camp: A Common API for Measuring Performance”, 21st Large Installations System Administration Conference (LISA '07), 2007, pp. 49-61. |
“McKesson Automation and Alaris Medical Systems Developing Point-of-Care Bar Coding Solution to Improve IV Medication Safety”, PR Newswire, NY, Dec. 9, 2002, pp. 4. |
“Software Versioning”, Wikipedia.org, dated Oct. 16, 2011 in 11 pages, https://en.wikipedia.org/w/index.php?title=Software_versioning&oldid=455859110. |
Sutton et al., “The Syntax and Semantics of the PROforma Guideline Modeling Language”, Journal of the American Medical Informatics Association, Sep./Oct. 2003, vol. 10, No. 5, pp. 433-443. |
Akridge, Jeannie, “New Pumps Outsmart User Error”, Healthcare Purchasing News, Apr. 2011, pp. 10, http://web.archive.org/web/20110426122450/http://www.hpnonline.com/inside/2011-04/1104-OR-Pumps.html. |
Alur et al., “Formal Specifications and Analysis of the Computer-Assisted Resuscitation Algorithm (CARA) Infusion Pump Control System”, International Journal on Software Tools for Technology Transfer, Feb. 2004, vol. 5, No. 4, pp. 308-319. |
Aragon, Daleen RN, Ph.D., CCRN, “Evaluation of Nursing Work Effort and Perceptions About Blood Glucose Testing in Tight Glycemic Control”, American Journal of Critical Care, Jul. 2006, vol. 15, No. 4, pp. 370-377. |
ASHP Advantage, “Improving Medication Safety in Health Systems Through Innovations in Automation Technology”, Proceedings of Educational Symposium and Educational Sessions during the 39th ASHP Midyear Clinical Meeting, Dec. 5-9, 2004, Orlando, FL, pp. 28. |
Beard et al., “Total Quality Pain Management: History, Background, Resources”, Abbott Laboratories, TQPM Survey History, available Feb. 2015 or earlier, pp. 1-3. |
Bektas et al., “Bluetooth Communication Employing Antenna Diversity”, Proceedings of Eight IEEE International Symposium on Computers and Communication, Jul. 2003, pp. 6. |
Bequette, Ph.D., “A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas”, Diabetes Technology & Therapeutics, Feb. 28, 2005, vol. 7, No. 1, pp. 28-47. |
Bequette, B. Wayne, Ph.D., “Analysis of Algorithms for Intensive Care Unit Blood Glucose Control”, Journal of Diabetes Science and Technology, Nov. 2007, vol. 1, No. 6, pp. 813-824. |
Braun, “Infusomat® Space and Accessories”, Instructions for Use, Nov. 2010, pp. 68. http://corp.bbraun.ee/Extranet/Infusionipumbad/Kasutusjuhendid/Vanad/Kasutusjuhend-Infusomat_Space(vers688J,inglise_k).pdf. |
Brownlee, Seth, “Product Spotlight: The Plum A+ with Hospira MedNet Infusion System”, PP&P Magazine, Dec. 2005, vol. 2, No. 7, pp. 2. |
Cannon, MD et al., “Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time”, Circulation, Feb. 16, 1999, vol. 99, pp. 751-756. |
Cardinal Health, “Alaris® Syringe Pumps” Technical Service Manual, Copyright 2002-2006, Issue 9, pp. 1-88, http://www.frankshospitalworkshop.com/equipment/documents/infusion_pumps/service_manuals/Cardinal_Alaris_-_Service_Manual.pdf. |
“CareAware® Infusion Management”, Cerner Store, as printed May 12, 2011, pp. 3, https://store.cerner.com/items/7. |
Chen et al., “Enabling Location-Based Services on Wireless LANs”, The 11th IEEE International Conference on Networks, ICON 2003, Sep. 28-Oct. 1, 2003, pp. 567-572. |
“Computer Dictionary”, Microsoft Press, Third Edition, Microsoft Press, 1997, pp. 430 & 506. |
“Context-Free Grammar”, Wikipedia.org, as last modified Mar. 5, 2010 in 11 pages, https://en.wikipedia.org/w/index.php/?title=Context-free_grammar&oldid=347915989. |
Crawford, Anne J., MSN, RNC, “Building a Successful Quality Pain Service: Using Patient Satisfaction Data and the Clinical Practice Guideline”, USA, 1995, pp. 1-6. |
Crocker et al., “Augmented BNF for Syntax Specifications: ABNF”, Network Working Group, Standards Track, Jan. 2008, pp. 16. |
Davidson et al., “A Computer-Directed Intravenous Insulin System Shown to be Safe, Simple, and Effective in 120,618 h of Operation”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2418-2423. |
Davies, T., “Cordless Data Acquisition in a Hospital Environment”, IEE Colloquium on Cordless Computing—Systems and User Experience, 1993, pp. 4. |
Dayhoff et al., “Medical Data Capture and Display: The Importance of Clinicians' Workstation Design”, AMIA, Inc., 1994, pp. 541-545. |
Diabetes Close Up, Close Concerns AACE Inpatient Management Conference Report, Consensus Development Conference on Inpatient Diabetes and Metabolic Control, Washington, D.C., Dec. 14-16, 2003, pp. 1-32. |
East PhD et al., “Digital Electronic Communication Between ICU Ventilators and Computers and Printers”, Respiratory Care, Sep. 1992, vol. 37, No. 9, pp. 1113-1122. |
Einhorn, George W., “Total Quality Pain Management: A Computerized Quality Assessment Tool for Postoperative Pain Management”, Abbott Laboratories, Chicago, IL, Mar. 2, 2000, pp. 1-4. |
Eskew et al., “Using Innovative Technologies to Set New Safety Standards for the Infusion of Intravenous Medications”, Hospital Pharmacy, 2002, vol. 37, No. 11, pp. 1179-1189. |
Felleiter et al., “Data Processing in Prehospital Emergency Medicine”, International journal of Clinical Monitoring and Computing, Feb. 1995, vol. 12, No. 1, pp. 37-41. |
Fogt et al., Development and Evaluation of a Glucose Analyzer for a Glucose-Controlled Insulin Infusion System (Biostator®), Clinical Chemistry, 1978, vol. 24, No. 8, pp. 1366-1372. |
Gage et al., “Automated Anesthesia Surgery Medical Record System”, International Journal of Clinical Monitoring and Computing, Dec. 1990, vol. 7, No. 4, pp. 259-263. |
Galt et al., “Personal Digital Assistant-Based Drug Information Sources: Potential to Improve Medication Safety”, Journal of Medical Library Association, Apr. 2005, vol. 93, No. 2, pp. 229-236. |
Gardner, Ph.D. et al., “Real Time Data Acquisition: Recommendations for the Medical Information Bus (MIB)”, 1992, pp. 813-817. |
“General-Purpose Infusion Pumps”, Health Devices, EXRI Institute, Oct. 1, 2002, vol. 31, No. 10, pp. 353-387. |
Givens et al., “Exploring the Internal State of User Interfaces by Combining Computer Vision Techniques with Grammatical Inference”, Proceedings of the 2013 International Conference on Software Engineering, San Francisco, CA, May 18-26, 2013, pp. 1165-1168. |
Glaeser, “A Hierarchical Minicomputer System for Continuous Post-Surgical Monitoring”, Computers and Biomedical Research, Aug. 31, 1975, pp. 336-361. |
Goldberg et al., “Clinical Results of an Updated Insulin Infusion Protocol in Critically Ill Patients”, Diabetes Spectrum, 2005, vol. 18, No. 3, pp. 188-191. |
Gomez et al., “CLAM: Connection-Less, Lightweight, and Multiway Communication Support for Distributed Computing”, Computer Science, 1997, vol. 1199, pp. 227-240. |
“GPS Tracker for Medical Equipment”, http://www.trackingsystem.com/forbusinesses/corporate-trackingsystem/1098-gps-tracker-formedicalequipment.html, Mar. 15, 2015, pp. 2. |
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 160. |
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump: Illustrated Parts List for Pump Serial Numbers from 3000 to 59,999”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 71. |
Halpern et al., “Changes in Critical Care Beds and Occupancy in the United States 1985-2000: Differences Attributable to Hospital Size”, Critical Care Medical, Aug. 2006, vol. 34, No. 8, pp. 2105-2112. |
Hamann et al., “PUMPSIM: A Software Package for Simulating Computer-Controlled Drug Infusion Pumps”, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1990, vol. 12, No. 5, pp. 2019-2020. |
Hasegawa et al., “On a Portable Memory Device for Physical Activities and Informations of Maternal Perception”, Journal of Perinatal Medicine, 1988, vol. 16, No. 4, pp. 349-356. |
Hawley et al., “Clinical Implementation of an Automated Medical Information Bus in an Intensive Care Unit”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 9, 1988, pp. 621-624. |
Hayes-Roth et al., “Guardian: A Prototype Intelligent Agent for Intensive-Care Monitoring”, Artificial Intelligence in Medicine, vol. 4, Dec. 31, 1992, pp. 165-185. |
Hospira, GemStar® Pain Management Infusion System 9-084-PR1-2-2, www.hospira.com/products/gemstar_painmanagement.aspx, Jan. 28, 2010, pp. 1-2. |
Introducing Abbott TQPM (Total Quality Pain Management), Abbott Laboratories, Abbott Park, IL, May 2000, pp. 1-4. |
“Infusion Pump”, Wikipedia.org, as last modified Mar. 27, 2014, in 3 pages, https://web.archive.org/web/20140703024932/https://en.wikipedia.org/wiki/Infusion_pump. |
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/US2015/028551, dated Nov. 10, 2016 in 9 pages. |
International Search Report and Written Opinion received in PCT Application No. PCT/US2015/028551, dated Jul. 29, 2015 in 10 pages. |
Isaka et al., “Control Strategies for Arterial Blood Pressure Regulation”, IEEE Transactions on Biomedical Engineering, Apr. 1993, vol. 40, No. 4, pp. 353-363. |
Johnson et al., “Using BCMA Software to Improve Patient Safety in Veterans Administration Medical Centers”, Journal of Healthcare Information Management, Dec. 6, 2004, vol. 16, No. 1, pp. 46-51. |
Kent Displays, “Reflex™ Electronic Skins”, Product Brief 25127B, 2009, pp. 2. |
Kent Displays, “Reflex Electronic Skins Engineering Evaluation Kit”, 25136A, Mar. 10, 2009. |
Lefkowitz et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System”, Hospital Pharmacy, Mar. 31, 1991, vol. 26, No. 3, pp. 239-242. |
Lenssen et al., “Bright Color Electronic Paper Technology and Applications”, IDS '09 Publication EP1-2 (Phillips Research), 2009, pp. 529-532. |
Leveson, Nancy, “Medical Devices: The Therac-25”, Appendix A, University of Washington, 1995, pp. 49. |
Linkens, D.A. “Computer Control for Patient Care”, Computer Control of Real-Time Processes, IEE Control Engineering Series 41, 1990, Ch. 13, pp. 216-238. |
Mako Hill et al., “The Official Ubuntu Book”, Shoeisha Co., Ltd., 1st Edition, Jun. 11, 2007, pp. 115 to 125. |
Marshall, et al., “New Microprocessor-Based Insulin Controller”, IEEE Transactions on Biomedical Engineering, Nov. 1983, vol. BME-30, No. 11, pp. 689-695. |
Martino et al., “Automation of a Medical Intensive Care Environment with a Flexible Configuration of Computer Systems”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 5, 1980, vol. 3, pp. 1562-1568. |
Matsunaga et al., “On the Use of Machine Learning to Predict the Time and Resources Consumed by Applications”, 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), May 17-20, 2010, pp. 495-504. |
Mauseth et al., “Proposed Clinical Application for Tuning Fuzzy Logic Controller of Artificial Pancreas Utilizing a Personalization Factor”, Journal of Diabetes Science and Technology, Jul. 2010, vol. 4, No. 4, pp. 913-922. |
Medfusion™, “Medfusion Syringe Infusion Pump Model 4000”, Operator's Manual, Software Version V1.1, Sep. 2011, pp. 154. http://www.medfusionpump.com/assets/literature/manuals/Operators_Manual_4000_40-5760-51A.pdf. |
Metnitz et al., “Computer Assisted Data Analysis in Intensive Care: the ICDEV Project-Development of a Scientific Database System for Intensive Care”, International Journal of Clinical Monitoring and Computing, Aug. 1995, vol. 12, No. 3, pp. 147-159. |
Micrel Medical Devices, “MP Daily +” http://web.archive.org/web/20130803235715/http://www.micrelmed.com/index.aspx?productid=9 as archived Aug. 3, 2013 in 1 page. |
Moghissi, Etie, MD, FACP, FACE, “Hyperglycemia in Hospitalized Patients”, A Supplement to ACP Hospitalist, Jun. 15, 2008, pp. 32. |
Murray, Jr. et al., “Automated Drug Identification System (during surgery)”, IEEE Proceedings of Southeastcon '91, Apr. 7-10, 1991, pp. 265. |
Nicholson et al., “‘Smart’ Infusion Apparatus for Computation and Automated Delivery of Loading, Tapering, and Maintenance Infusion Regimens of Lidocaine, Procainamide, and Theophylline”, Proceedings of the Seventh Annual Symposium on Computer Applications in Medical Care, Oct. 1983, pp. 212-213. |
Nolan et al., “The P1073 Medical Information Bus Standard: Overview and Benefits for Clinical Users”, 1990, pp. 216-219. |
Omnilink Systems, Inc., “Portable Medical Equipment Tracking”, http://www.omnilink.com/portablemedicalequipmenttracking/, Mar. 15, 2015, pp. 2. |
O'Shea, Kristen L., “Infusion Management: Working Smarter, Not Harder”, Hospital Pharmacy, Apr. 2013, vol. 48, No. 3, pp. S1-S14. |
Package Management in Debian GNU/Linux, Debian GNU/Linux Expert Desktop Use Special, Giutsu-Hyohron Co., Ltd., First Edition, Sep. 25, 2004, pp. 183-185. |
Passos et al., “Distributed Software Platform for Automation and Control of General Anaesthesia”, Eighth International Symposium on Parallel and Distributed Computing, ISPDC '09, Jun. 30-Jul. 4, 2009, pp. 8. |
Philips, “IntelliSpace Event Management and IntelliVue Patient Monitoring”, Release 10, 2011, http://incenter.medical.philips.com/doclib/enc/fetch/2000/4504/577242/577243/577247/582646/583147/8359175/Philips_Patient_Monitoring_and_IntelliSpace_Event_Management_Interoperability.pdf%3fnodeid%3d8508574%26vernum%3d-2, pp. 2. |
Pretty et al., “Hypoglycemia Detection in Critical Care Using Continuous Glucose Monitors: An in Silico Proof of Concept Analysis”, Journal of Diabetes Science and Technology, Jan. 2010, vol. 4, No. 1, pp. 15-24. |
Rappoport, Arthur E., “A Hospital Patient and Laboratory machine-Readable Identification System (MRIS) Revisited”, Journal of Medical Systems, Apr. 1984, vol. 8, Nos. 1/2, pp. 133-156. |
Ritchie et al., “A Microcomputer Based Controller for Neuromuscular Block During Surgery”, Annals of Biomedical Engineering, Jan. 1985, vol. 13, No. 1, pp. 3-15. |
Saager et al., “Computer-Guided Versus Standard Protocol for Insulin Administration in Diabetic Patients Undergoing Cardiac Surgery”, Annual Meeting of the American Society of Critical Care Anesthesiologists, Oct. 13, 2006. |
Sanders et al., “The Computer in a Programmable Implantable Medication System (PIMS)”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 2, 1982, pp. 682-685. |
Schilling et al., “Optimizing Outcomes! Error Prevention and Evidence-Based Practice with IV Medications”, A Pro-Ce Publication, Hospira, Inc., Feb. 6, 2012, pp. 56. |
Schulze et al., “Advanced Sensors Technology Survey”, Final Report, Feb. 10, 1992, pp. 161. |
Scott, et al., “Using Bar-Code Technology to Capture Clinical Intervention Data in a Hospital with a Stand-Alone Pharmacy Computer System”, Mar. 15, 1996, American Journal of Health-System Pharmacy, vol. 53, No. 6, pp. 651-654. |
Sebald et al., “Numerical Analysis of a Comprehensive in Silico Subcutaneous Insulin Absorption Compartmental Model”, 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Sep. 2-6, 2009, pp. 3901-3904. |
Shabot, M. Michael, “Standardized Acquisition of Bedside Data: The IEEE P1073 Medical Information Bus”, International Journal of Clinical Monitoring and Computing, vol. 6, Sep. 27, 1989, pp. 197-204. |
Sheppard, Louis, Ph.D., “Automation of the Infusion of Drugs Using Feedback Control”, Journal of Cardiothoracic and Vascular Anesthesia, Feb. 28, 1989, vol. 3, No. 1, pp. 1-3. |
Sheppard, Louis, Ph.D., “Computer Control of the Infusion of Vasoactive Drugs”, Annals of Biomedical Engineering, Jul. 1980, vol. 8, No. 4-6, pp. 431-444. |
Sheppard, Louis, Ph.D., “The Application of Computers to the Measurement, Analysis, and Treatment of Patients Following Cardiac Surgical Procedures”, The University of Alabama in Birmingham, Oct. 31, 1977, pp. 297-300. |
Sheppard, Louis, Ph.D., “The Computer in the Care of Critically Ill Patients”, Proceedings of the IEEE, Sep. 1979, vol. 67, No. 9, pp. 1300-1306. |
“Sigma Spectrum: Operator's Manual”, Oct. 2009, pp. 72. http://static.medonecapital.com/manuals/userManuals/Sigma-Spectrum-Operator-Manual-October-2009.pdf. |
Simonsen, Michael Ph.D., POC Testing, New Monitoring Strategies on Fast Growth Paths in European Healthcare Arenas, Biomedical Business & Technology, Jan. 2007, vol. 30, No. 1, pp. 1-36. |
Siv-Lee et al., “Implementation of Wireless ‘Intelligent’ Pump IV Infusion Technology in a Not-for-Profit Academic Hospital Setting”, Hospital Pharmacy, Sep. 2007, vol. 42, No. 9, pp. 832-840. http://www.thomasland.com/hpj4209-832.pdf. |
Slack, W.V., “Information Technologies for Transforming Health Care”, https://www.andrew.cmu.edu/course/90-853/medis.dir/otadocs.dir/03ch2.pdf, Ch. 2, 1995, pp. 29-78. |
Smith, Joe, “Infusion Pump Informatics”, CatalyzeCare: Transforming Healthcare, as printed May 12, 2011, pp. 2. |
Sodders, Lisa, “VA Center Keeps Medicine in Right Hands”, The Capital-Journal, Dec. 4, 1999, pp. 1-2. |
Stitt, F.W., “The Problem-Oriented Medical Synopsis: a Patient-Centered Clinical Information System”, Proceedings of the Annual Symposium on Computer Application in Medical Care, 1994, pp. 88-92. |
Stokowski, Laura A. RN, MS, “Using Technology to Improve Medication Safety in the Newborn Intensive Care Unit”, Advances in Neonatal Care, Dec. 2001, vol. 1, No. 2, pp. 70-83. |
Szeinbach et al., “Automated Dispensing Technologies: Effect on Managed Care”, Journal of Managed Care Pharmacy (JMCP), Sep./Oct. 1995, vol. 1, No. 2, pp. 121-127. |
Szolovits et al., “Guardian Angel: Patient-Centered Health Information Systems”, Technical Report MIT/LCS/TR-604, Massachusetts Institute of Technology Laboratory for Computer Science, May 1994, pp. 39. |
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in Critically Ill Patients”, The New England Journal of Medicine, Nov. 8, 2001, vol. 345, No. 19, pp. 1359-1367. |
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in the Medical ICU”, The New England Journal of Medicine, Feb. 2, 2006, vol. 354, No. 5, pp. 449-461. |
Van Der Maas et al., “Requirements for Medical Modeling Languages”, Journal of the American Medical Informatics Association, Mar./Apr. 2001, vol. 8, No. 2, pp. 146-162. |
Villalobos et al., “Computerized System in Intensive Care medicine”, Medical Informatics, vol. 11, No. 3, 1986, pp. 269-275. |
Wilkins et al., “A Regular Language: The Annotated Case Report Form”, PPD Inc., PharmaSUG2011—PaperCD18, 2011, pp. 1-9. |
Ying et al., “Regulating Mean Arterial Pressure in Postsurgical Cardiac Patients. A Fuzzy Logic System to Control Administration of Sodium Nitroprusside”, IEEE Engineering in Medicine and Biology Magazine, vol. 13, No. 5, Nov.-Dec. 1994, pp. 671-677. |
Yue, Ying Kwan, “A Healthcare Failure Mode and Effect Analysis on the Safety of Secondary Infusions”, Thesis, Institute of Biomaterials and Biomedical Engineering, University of Toronto, 2012, pp. 168. |
Yurkonis et al., “Computer Simulation of Adaptive Drug Infusion”, IEEE Transactions on Biomedical Engineering, vol. BME-34, No. 8, Aug. 1987, pp. 633-635. |
Zakariah et al., “Combination of Biphasic Transmittance Waveform with Blood Procalcitonin Levels for Diagnosis of Sepsis in Acutely Ill Patients”, Critical Care Medicine, 2008, vol. 36, No. 5, pp. 1507-1512. |
Ahn et al., “Towards Scalable Authentication in Health Services”, Eleventh IEEE International Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises, Jun. 2002, pp. 83-88. |
Bellare et al., “Security Proofs for Identity-Based Identification and Signature Schemes”, Lecture Notes in Computer Science, Jan. 2009, vol. 22, No. 1, pp. 18. |
Doesburg et al., “Improved Usability of a Multi-Infusion Setup Using a Centralized Control Interface: A Task-Based Usability Test”, Aug. 11, 2017, PLoS One, vol. 12, No. 8, pp. 10. |
Huang et al., “Secure Identity-Based Data Sharing and Profile Matching for Mobile Healthcare Social Networks in Cloud Computing”, vol. 6, Jul. 2018, pp. 36584-36594. |
Li et al., “Hijacking an Insulin Pump: Security Attacks and Defenses for a Diabetes Therapy System”, 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services, 2011, pp. 150-156. |
Michienzi, Kelly, “Managing Drug Library Updates”, Pharmacy Purchasing Products, https://www.pppmag.com/article/1061, Feb. 2012, vol. 9, pp. 22-23. |
“Sigma Spectrum: Operator's Manual”, May 15, 2008, pp. 63. <https://usme.com/content/manuals/sigma-spectrum-operator-manual.pdf>. |
“TCG TPM v2.0 Provisioning Guidance”, Reference, Version 1, Revision 1, Mar. 15, 2017, pp. 1-43. |
Number | Date | Country | |
---|---|---|---|
20210252210 A1 | Aug 2021 | US |
Number | Date | Country | |
---|---|---|---|
61986562 | Apr 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16846882 | Apr 2020 | US |
Child | 17157597 | US | |
Parent | 16408272 | May 2019 | US |
Child | 16846882 | US | |
Parent | 15674889 | Aug 2017 | US |
Child | 16408272 | US | |
Parent | 14700357 | Apr 2015 | US |
Child | 15674889 | US |